POPULARITY
62 episodes with idsa
11 episodes with idsa
8 episodes with idsa
5 episodes with idsa
5 episodes with idsa
4 episodes with idsa
4 episodes with idsa
3 episodes with idsa
2 episodes with idsa
On episode #80 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 4/24/25 – 5/7/25. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus-Mismatched Adult and Pediatric Solid Organ Transplant Recipients (Transplant Infectious Disease) Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023–2024 (American Academy of Pediatrics) Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants (Influenza and other respiratory viruses) Hospital admissions of respiratory infections in infants plungewith nirsevimab RSV antibody (CIDRAP) Time to antiviral treatment in mild–moderate COVID-19 in the emergency department (Internal and Emergency Medicine) Delays in COVID antiviral receipt raised risk of poor outcomes after ED visits by 18%, data suggest (CIDRAP) Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV (MMWR) Bacterial Validation and clinical implementation of cerebrospinal fluid C-reactive protein for the diagnosis of bacterial meningitis (LANCET: Regional Health) Bridging to transplant: TDM-Guided Outpatient Dalbavancin Therapy in Chronic Granulomatous Disease with deep-seeded Inoperable Abscesses over 11 Months (OFID) Nitrites for Urinary Tract Infection—Time to Say Goodbye? (JAMA: Internal Medicine) Fungal The Last of US Season 2 (YouTube) High Mortality and Associated Risk Factors in Kidney Transplant Recipients with Cryptococcosis – A Nationwide Cohort Study Over a Decade Using USRDS Data (OFID) Use of Dog Serologic Data for Improved Understanding of Coccidioidomycosis (JID) Parasitic Performance of a novel P. falciparum rapid diagnostic test in areas of widespread hrp2/3 gene deletion (CID) Prevalence of Anopheles stephensi in the Horn of Africa: a systematic review and meta-analysis (BMC Infectious Diseases) Raising awareness of Demodex mites: a neglected cause of skin disease (Infection) Miscellaneous Scientific Integrity Under Threat: The Role of the IDSA, PIDS, and SHEA Journals in an Evolving Political Landscape (CID) Reasoning on Rounds Volume 2: a Framework for Teaching Management Reasoning in the Inpatient Setting (Journal of General Internal Medicine) Billing for and documentation of provider-to-provider interprofessional consults in infectious diseases (Journal of the Pediatric Infectious Diseases Society) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.
In the last decade, there have been major changes in the approach of the treatment of pneumonia, in particular, with the availability of new diagnostic tools. Additionally, new drugs have been approved for the treatment of pneumonia. We discuss the approach to the management of pneumonia with a person who has spent most of his professional career working on this topic. Topics discussed: Definitions and nomenclature of pneumonia and evolution of these terms Changes in the diagnosis of pneumonia Ttherapeutic changes and future approaches for the treatment of pneumonia. Guest: Daniel M Musher, M.D. Links: ASM and IDSA launch the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) in 2026 This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal. Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
Send us a textDr. Michael Osterholm, PhD, MPH ( https://www.cidrap.umn.edu/michael-t-osterholm-phd-mph ) is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the Director of the Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, a professor in the Technological Leadership Institute, College of Science and Engineering, and an adjunct professor in the Medical School, all at the University of Minnesota. Dr. Osterholm is also a member of the National Academy of Medicine (NAM) and the Council of Foreign Relations. In June 2005 Dr. Osterholm was appointed by Michael Leavitt, Secretary of the Department of Health and Human Services (HHS), to the newly established National Science Advisory Board on Biosecurity. In July 2008, he was named to the University of Minnesota Academic Health Center's Academy of Excellence in Health Research. In October 2008, he was appointed to the World Economic Forum Working Group on Pandemics.Dr. Osterholm is an internationally recognized expert in infectious disease epidemiology and is the author of more than 300 papers and abstracts, including 20 book chapters, and New York Times best-selling 2017 book, Deadliest Enemy: Our War Against Killer Germs ( https://www.amazon.com/Deadliest-Enemy-Against-Killer-Germs/dp/0316343692 ).Dr. Osterholm's new book will be coming out in September, 2025, entitled The Big One: How We Must Prepare for Future Deadly Pandemics ( https://www.amazon.com/Big-One-Prepare-World-Altering-Pandemics-ebook/dp/B0C1G5BHG3 ).Dr. Osterholm has received numerous honors for his work, including an honorary doctorate from Luther College; the Pump Handle Award, CSTE; the Charles C. Shepard Science Award, CDC; the Harvey W. Wiley Medal, FDA; the Squibb Award, IDSA; Distinguished University Teaching Professor, Environmental Health Sciences, School of Public Health, UMN; and the Wade Hampton Frost Leadership Award, American Public Health Association. He also has been the recipient of six major research awards from the NIH and the CDC.Dr. Osterholm received his PhD and MS in Environmental Health, and MPH in Epidemiology, from the University of Minnesota. #MichaelOsterholm #InfectiousDisease #CenterForInfectiousDiseaseResearchAndPolicy #CIDRAP #PublicHealth #AntimicrobialStewardship #VaccineIntegrityProject #AntimicrobialResistance #MinnesotaDepartmentOfHealth #Epidemiologist #ToxicShockSyndrome #FoodborneIllness #Hepatitis #Biodefense #Countermeasures #ChronicWastingDisease #Preparedness #Policy #Surveillance #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show
Join Jeff and Jim in this episode of the Identity at the Center Podcast as they delve into the upcoming Identity Management Day 2025. Featuring guest Jeff Reich, Executive Director at the Identity Defined Security Alliance (IDSA), this episode unpacks the significance of non-human identities, AI in identity management, and the existential questions surrounding identity. The discussion covers upcoming events, awards, and what to expect from Identity Management Day, while also exploring the potential impact of Quantum Computing. Don't miss out on this in-depth conversation that combines humor with profound insights into the evolving landscape of identity management.Chapters00:00 Introduction and Identity Concerns01:30 AI and Podcasting01:59 AI Limitations and Future05:41 Conference Announcements07:30 Identity Management Day 202509:35 Global Identity Trends18:39 Existential Identity and AI27:29 The Concept of Identity in Technology28:05 Machine Identity and Its Implications29:30 Human vs. Machine Identity31:07 The Future of Identity with AI and Quantum Computing38:13 Identity Management Day Awards45:17 Fun and Lighthearted Discussion51:35 Conclusion and Final ThoughtsConnect with Jeff: https://www.linkedin.com/in/jreich/Learn more about the IDSA: https://www.idsalliance.org/Register for Identity Management Day 2025: https://www.accelevents.com/e/Identity-Management-Day-2025-Virtual-ConferenceConnect with us on LinkedIn:Jim McDonald: https://www.linkedin.com/in/jimmcdonaldpmp/Jeff Steadman: https://www.linkedin.com/in/jeffsteadman/Visit the show on the web at http://idacpodcast.comKeywords: Identity Management, AI, Non-Human Identities, Identity Defined Security Alliance, IDSA, Quantum Computing, Identity Management Day 2025, Identity at the Center Podcast.
ESCMID Global, ESCMID's flagship congress, kicks off this Friday in Vienna. In light of that, Angela Huttner and Thomas Tängdén sit down with ESCMID leadership, President Robert Skov and Immediate-Past President Annelies Zinkernagel in this episode of Communicable. Together they discuss the roles of medical societies like ESCMID in shaping healthcare policy, the importance of scientific communication, and lessons learned from the COVID pandemic. The conversation highlights ESCMID's priorities for the future on addressing antimicrobial resistance, fostering international collaboration and new educational initiatives. The episode also features personal anecdotes about what makes coming together at ESCMID Global so special. Tune in for a comprehensive look at how ESCMID is championing medical progress in infection for a healthier tomorrow.This episode was edited by Kathryn Hostettler and not peer reviewed.ReferencesGlobal impact of US policy changes: The ESCMID perspective. CMI Comms 2025;2(2): 105073.Malani AN, Sharland M, Clancy CJ, Skov R, ESCMID & IDSA Executive Boards. A global call to action to fight antimicrobial resistance: IDSA and ESCMID joint white paper. CMI Comms 2024; 1(2): 105033.Baghdadi JD & Morgan DJ. Diagnostic tests should be assessed for clinical impact. CMI Comms 2024; 1(2): 105010.
Dr. John Fleetham chats with Dr. Sonal Munsiff and Dr. Raquel Duarte about their article, "Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline."
IT'S A BREAKPOINTS BREAKOUT!Jame and Callum are joined by the drugnamic duo of Julie-Ann Justo & Erin McCreary from the Breakpoints podcast to delve into the IDSA DTR Gram negative Guidance.Show notes for this episode are here.Breakpoints podcast can be found here: https://breakpoints-sidp.org/Lyrics: Tryin' to use some drugs to kill these bugsErin and Julie are PK PD thugs Gonna make these two ID:IOTS look like mugsIt's gonna be a Breakpoints BreakoutSorry the song sounds so tinny, Podcast host is doing something strange to it. Link to original MP3 here. Send us a textSupport the showQuestions, comments, suggestions to idiotspodcasting@gmail.com or on Bluesky @idiots-pod.bsky.socialPrep notes for completed episodes can be found here (Not all episodes have prep notes).If you are enjoying the podcast please leave a review on your preferred podcast app!Feel like giving back? Donations of caffeine gratefully received!https://www.buymeacoffee.com/idiotspod
On episode #75 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 2/13/25 – 2/26/25. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral VIMKUNYA (FDA) Co-infection of SARS‐CoV‐2 and influenza A/B among patients with COVID-19(BMC Infectious Diseases) Measles (Texas Health and Human Services) 2025 Measles outbreak guidelines (New Mexico Health) BTN: Beyond the Noise with Paul Offit (microbeTV) Rubeola response (febrile) Timing of influenza antiviral therapy and risk of death in adults hospitalized with influenza-associated pneumonia, influenza hospitalization surveillance network (FluSurv-NET), 2012–2019 (CID) Mother-child dyads living with HIV in the Western Cape, South Africa: undetectable = undetectable? (Journal of the International AIDS Society) Early impacts of the PEPFAR stop-work order: a rapid assessment(Journal of the International AIDS Society) Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study (LANCET: Infectious Diseases) Bacterial Effects of extended anaerobic antibiotic coverage on anaerobic bloodstream infection: A multisite retrospective stud (International Journal of Infectious Diseases) The effectiveness of newer Beta-Lactams for the treatment of antimicrobial-resistant gram-negative meningitis (CID) Treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a aeta-analysis of macrolides versus tetracycline (The Pediatric Infectious Disease Journal) Fungal The Last of US Season 2 (YouTube) Concordance of noninvasive plasma cell-free DNA With invasive diagnostics for diagnosis of invasive fungal disease (CID) Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit(Intensive Care Medicine) Parasitic Epidemiologic Investigation of Protozoa and soil-transmitted helminths in Starr County, Texas (American J Trop Med and Hyg) Post-artesunate delayed hemolysis in African children with severe malaria: incidence, medical impact and prevention (CID) Miscellaneous Telehealth (Medicare.gov) Public comment: IDSA guideline on management and treatment of complicated urinary tract infections (IDSA) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.
30 years ago: Computer industry booms as consoles slump, Nintendo announces Ultra64 & The internet gets scary These stories and many more on this episode of the VGNRTM! This episode we will look back at the biggest stories in and around the video game industry in August 1994. As always, we'll mostly be using magazine cover dates, and those are of course always a bit behind the actual events. Alex Smith of They Create Worlds is our cohost. Check out his podcast here: https://www.theycreateworlds.com/ and order his book here: https://www.theycreateworlds.com/book Get us on your mobile device: Android: https://www.google.com/podcasts?feed=aHR0cHM6Ly92aWRlb2dhbWVuZXdzcm9vbXRpbWVtYWNoaW5lLmxpYnN5bi5jb20vcnNz iOS: https://podcasts.apple.com/de/podcast/video-game-newsroom-time-machine And if you like what we are doing here at the podcast, don't forget to like us on your podcasting app of choice, YouTube, and/or support us on patreon! https://www.patreon.com/VGNRTM Send comments on Mastodon @videogamenewsroomtimemachine@oldbytes.space Or twitter @videogamenewsr2 Or Instagram https://www.instagram.com/vgnrtm Or videogamenewsroomtimemachine@gmail.com Links: If you don't see all the links, find them here: https://www.patreon.com/posts/123352781/edit 7 Minutes in Heaven: Cliffhanger (Amiga) Video Version: https://youtu.be/KZ7J9qEpqxI https://www.mobygames.com/game/29830/cliffhanger/ Corrections: July 1994 Ep - https://www.patreon.com/posts/july-1994-part-1-116538490 https://www.patreon.com/posts/july-1994-part-2-116538674 Ethan's fine site The History of How We Play: https://thehistoryofhowweplay.wordpress.com/ Defunctland Jim Henson Series - https://youtu.be/BVoGf1JTVeI?si=PBwUInz2t7hBe-Eq https://en.wikipedia.org/wiki/Information_superhighway https://en.namu.wiki/w/RX-78%20Gundam https://fallout.fandom.com/wiki/SPECIAL https://www.theycreateworlds.com/episodes/TCW164 https://en.wikipedia.org/wiki/Monte_Cook Wrestling with Games - XBAND - https://youtu.be/k_5M-z_RUKA?si=tuuDxPGj6GnTPc-B https://en.wikipedia.org/wiki/Steam_(service) 1994: Canada to get their own ratings New VCR proves 6 heads are better than 1, The Toronto Star, August 11, 1994,Thursday, FINAL EDITION, Section: FAST FORWARD; Pg. F2, byline: BY ROBERT WRIGHT TORONTO STARON THE EDGE California presses forward with video game violence bill https://www.retromags.com/files/file/3018-egm2-issue-02-august-1994/ pg. 29 https://www.latimes.com/archives/la-xpm-1994-04-13-mn-45306-story.html IDSA board selected Mattel takes a second look at games Mattel Hires Sega Executive, The Associated Press, August 2, 1994, Tuesday, BC cycle Square goes public CORPORATE PROFILE: SQUARE, Jiji Press Ticker Service, AUGUST 5, 1994, FRIDAY Japanese companies playing with fire "As derivatives proliferate, so do worries Companies try to control risks from transactions intended to rein in costs but which can backfire, The Nikkei Weekly (Japan), August 15, 1994, Section: FINANCE; Pg. 13, Byline: BY ASAKO ISHIBASHI Staff writer" Acclaim buys Valiant ACCLAIM ACQUIRES VOYAGER COMMUNICATIONS FOR $65 MILLION Marks Company's Diversification into Comic Book Publishing, Business Wire, August 2, 1994, Tuesday https://en.wikipedia.org/wiki/Comic_book_collecting#Bust_of_the_speculator_market UK video rental market embraces games... illegally Games Spark Sagging U.K. Vid Biz; But Many Don't Have Licenses To Rent Them, Billboard, August 13, 1994, Section: HOME VIDEO; Pg. 76, Byline: BY PETER DEAN Sonic out to zap the 'swapping' boom, The Scotsman, August 23, 1994, Tuesday, Byline: By Chris Mullinger UK teens tune out to games MEDIA GUARDIAN: LUST FOR NASTIES AND HARD NEWS, The Guardian (London), August 8, 1994, Section: THE GUARDIAN FEATURES PAGE; Pg. T17 Sega announces US theme park Universal Teams With Sega on Theme Park, Disneyland Annex Scaled Back, The Associated Press, August 12, 1994, Friday, AM cycle, Section: Business News, Byline: By E. SCOTT RECKARD, AP Business Writer Report: Sega Plan to Open 50 High-Tech Theme Parks in U.S., The Associated Press, August 16, 1994, Tuesday, BC cycle, Section: Business News Sega buys Data East Pinball Sega acquires Data East Pinball, Business Wire, August 26, 1994, Friday Doom coming to arcades DOOM IS ALL AROUND US, Business Week, August 1, 1994, Business and Industry, Section: Pg. 72; https://doom.fandom.com/wiki/Trivia https://www.doomworld.com/forum/topic/112509-share-your-epic-doom-related-stories/ Atari Games President passes Play Meter, August 1994, pg. 32 Hasbro readies to enter VR market No Headline In Original, ADWEEK, August 15, 1994, Eastern Edition, Byline: By Jennifer Comiteau and Penny Warneford, with Cathy Taylor https://www.unseen64.net/2018/10/04/hasbro-toaster-virtual-reality-console/ Begone Project Reality, all hail Ultra 64 https://www.retromags.com/files/file/3018-egm2-issue-02-august-1994/ pg. 28 Sega teams up with Hitachi in Japan HITACHI SALES TO HELP SEGA MARKET VIDEO GAMES, Jiji Press Ticker Service, AUGUST 3, 1994, WEDNESDAY Sega, Hitachi Sales link up to sell video game machine, Japan Economic Newswire, AUGUST 3, 1994, WEDNESDAY Sega buys Cross Products The leading video game development tool, Business Wire, August 15, 1994, Monday https://segaretro.org/Cross_Products https://web.archive.org/web/19961227100911/http://www.crossprod.co.uk/ Jaguar CD to launch by Xmas https://www.retromags.com/files/file/3018-egm2-issue-02-august-1994/ pg. 29 ATARI CORP. ANNOUNCES SECOND QUARTER 1994 RESULTS, PR Newswire, August 1, 1994, Monday - 19:55 Eastern Time, Section: Financial News Sanyo gives console market a TRY SANYO TO RELEASE INTERACTIVE GAME MACHINE TRY, Jiji Press Ticker Service, AUGUST 31, 1994, WEDNESDAY 3DO announces losses Video Game System Company Posts $ 16.1 Million First-Quarter Loss, The Associated Press, August 11, 1994, Thursday, AM cycle, Section: Business News COMPANY NEWS; SHARES OF 3DO SOAR ON FORECAST FOR NEW SYSTEM, The New York Times, August 24, 1994, Wednesday, Late Edition - Final, Distribution: Financial Desk, Section: Section D; ; Section D; Page 3; Column 1; Financial Desk ; Column 1; 3DO UNVEILS PLANS TO BOOST POWER OF GAME PLAYERS, WALL STREET JOURNAL, August 25, 1994, Thursday, Section: Section B; Page 8, Column 4, Byline: BY JIM CARLTON ANOTHER KEY EXEC DEPARTS O&M'S, INTERACTIVE GROUP; 3DO POWERS UP TO MEET COMPETITION; INTERACTING:; OTHER NEWS: Advertising Age, August 29, 1994, Section: Pg. 14 Mortal Friday gets $10 million budget ACCLAIM'S 'MORTAL KOMBAT II' PREPARED TO STRIKE ON 'MORTAL FRIDAY,' SEPTEMBER 9; Company Spending Over $10 Million on Global Launch, Business Wire, August 4, 1994, Thursday https://archive.org/details/Computer_Gaming_World_Issue_121/page/n29/mode/2up Acclaim buys into FMV Playthings, August 1994, pg. 19 https://archive.org/details/GamePro_Issue_061_August_1994/page/n157/mode/1up?view=theater Macromedia and Microware want to bring PCs and ITV together Agreement to Make Computer Programs Available for Interactive TV Use, The Associated Press, August 1, 1994, Monday, AM cycle, Section: Business News, Byline: By STEVEN P. ROSENFELD, AP Business Writer https://en.wikipedia.org/wiki/Macromedia https://en.wikipedia.org/wiki/Microware Computer industry profits boom Not drowning, waving at profits, The Age (Melbourne, Australia), August 2, 1994 Tuesday, Late Edition, Section: COMPUTERS; Mass Storage; Pg. 34 SPA reports huge boom in sales "NORTH AMERICAN PC SOFTWARE SALES REACH $1.48 BILLION, IN FIRST QUARTER 1994; HOME EDUCATION SALES LEAD GROWTH -- UP 128%, PR Newswire, August 8, 1994, Monday - 14:29 Eastern Time, Section: Financial News" CDRom bundles discouraging sales Dataquest Consumer Survey Shows Where CD-ROM Title Developers Can Be Successful, Business Wire, August 8, 1994, Monday Sirius Publishing to release long-awaited 5-ft. 10-Pak Volume II, Business Wire, August 8, 1994, Monday https://archive.org/details/PC-Player-German-Magazine-1994-08/page/n15/mode/2up https://archive.org/details/Electronic-Games-1994-08/page/14/mode/2up Flash memory prices tumbling Not drowning, waving at profits, The Age (Melbourne, Australia), August 2, 1994 Tuesday, Late Edition, Section: COMPUTERS; Mass Storage; Pg. 34 https://en.wikipedia.org/wiki/Flash_memory Cyrix to take on AMD Infoworld August 8, 1994, pg. 5 Employers begin to crackdown on games Games they play, The Times, August 1, 1994, Monday, Section: Business, Byline: Jon Ashworth Microsoft targets "loosely supervised Executives" SUNDAY, August 7, 1994; Playing Games at Work, The New York Times, August 7, 1994, Sunday, Late Edition - Final, Distribution: Magazine Desk, Section: Section 6; ; Section 6; Page 12; Column 1; Magazine Desk ; Column 1; MacPlay expands lineup Playthings, August 1994, pg. 44 Ad game business booming in Germany https://archive.org/details/PC-Player-German-Magazine-1994-08/page/n29/mode/2up Media Vision collapse profiled https://archive.org/details/Electronic-Games-1994-08/page/10/mode/2up https://archive.org/details/Electronic-Games-1994-08/page/12/mode/2up Victormaxx announces Cybermaxx Virtual Reality Headset For PCs A Reality, Newsbytes News Network, August 5, 1994 http://videogamekraken.com/cybermaxx-by-victormaxx Mice go 3D Echoes of Silicon Valley, Agence France Presse -- English, August 04, 1994 08:13 Eastern Time, Section: Domestic, non-Washington, general news item, Dateline: PALO ALTO, California, Aug 4 https://www.ebay.com/itm/304724946528 Microprose to bring Magic to PC IT'S IN THE CARDS' FOR MICROPROSE(R) AND WIZARDS OF THE COAST(R);PR Newswire, August 10, 1994, Wednesday - 17:23 Eastern Time, Section: State and Regional News https://www.mobygames.com/game/530/magic-the-gathering/ https://www.mobygames.com/game/6274/magic-the-gathering-battlemage/ Star Trek licenses are a mess https://archive.org/details/Electronic-Games-1994-08/page/14/mode/2up TEN to bring SimCity online Total Entertainment Network will feature online debut of popular SimCity, game, Business Wire, August 10, 1994, Wednesday The web becomes a scary place E-mail evil, The Jerusalem Post, August 4, 1994, Thursday, Section: OPINION; Pg. 6, Byline: SANDY ROVNER Siliwood goes Online DISNEY, AMERITECH, BELLSOUTH AND SOUTHWESTERN BELL PLAN ALLIANCE TO DEVELOP AND OFFER VIDEO SERVICES, PR Newswire, August 8, 1994, Monday - 13:31 Eastern Time, Section: Financial News Fujitsu brings habitat back to USA Fujitsu to start 'cyberspace' game business in U.S., Japan Economic Newswire, AUGUST 10, 1994, WEDNESDAY Computer Porn outpacing UK lawmakers https://archive.org/details/Atari_ST_User_Issue_103_1994-08_Europress_GB/page/n39/mode/2up Labor promises telecommunications reform Party line for fun and games, The Times, August 5, 1994, Friday, Byline: Emma Woollacott https://en.wikipedia.org/wiki/Mercury_Communications Interactive TV license purchasers default SOME TOP BIDDERS AT AIRWAVE AUCTION FAILING TO PAY UP, Pittsburgh Post-Gazette (Pennsylvania), AUGUST 12, 1994, FRIDAY, SOONER EDITION, Section: BUSINESS, Byline: BLOOMBERG BUSINESS NEWS Acorn enters set top box market https://archive.org/details/AcornUser145-Aug94/page/n7/mode/2up Ziff Davis buys Compute ZIFF-DAVIS ACQUIRES ASSETS OF COMPUTE MAGAZINE; COMPUTER LIFE AND FamilyPC'S ADVERTISERS TO GET UNEXPECTED BONUS CIRCULATION, PR Newswire, August 8, 1994, Monday - 19:06 Eastern Time Teenage reviewers on the rise Teenage games writers get to call the shots, The Age (Melbourne, Australia), August 2, 1994 Tuesday, Late Edition, Section: COMPUTERS; Pg. 40, Byline: Amy Harmon Computer game book rights up for grabs Book Notes, The New York Times, August 3, 1994, Wednesday, Late Edition - Final, Distribution: Cultural Desk, Section: Section C; ; Section C; Page 20; Column 5; Cultural Desk ; Column 5;,Byline: By Sarah Lyall https://en.wikipedia.org/wiki/List_of_novels_based_on_video_games Disney gets MYST rights Out of the 'Myst': Disney plays game for book, film; Hit CD-ROM software is going Hollywood, The Hollywood Reporter, August 11, 1994, Thursday, Byline: Scott Hettrick Stormfront to simulate strike season PENDING BASEBALL STRIKE PROMPTS VIDEO GAME DEVELOPER TO PINCH HIT FOR REAL THING, PR Newswire, August 12, 1994, Friday - 09:02 Eastern Time, Section: Financial New Real Unreal Baseball, The Associated Press, August 17, 1994, Wednesday, PM cycle, Section: Sports News, Byline: By JIM LITKE, AP Sports Writer Indians overtake White Sox in AL Central; Braves, Expos torrid in Nintendo, Baseball League, Business Wire, August 21, 1994, Sunday Leonard Herman releases Phoenix https://www.latimes.com/archives/la-xpm-1994-04-13-mn-45306-story.html pg. 32 Nintendo ordered to pay $208 million Nintendo U.S. unit told to pay 208 mil. dlrs in damages, Japan Economic Newswire, AUGUST 2, 1994, TUESDAY https://archive.org/details/Electronic-Games-1994-08/page/14/mode/2up No Headline in Original, Ad Day, August 8, 1994, Section: Corridor Talk Pg. 38, byline: Kevin Kerr Recommended Links: The History of How We Play: https://thehistoryofhowweplay.wordpress.com/ Gaming Alexandria: https://www.gamingalexandria.com/wp/ They Create Worlds: https://tcwpodcast.podbean.com/ Digital Antiquarian: https://www.filfre.net/ The Arcade Blogger: https://arcadeblogger.com/ Retro Asylum: http://retroasylum.com/category/all-posts/ Retro Game Squad: http://retrogamesquad.libsyn.com/ Playthrough Podcast: https://playthroughpod.com/ Retromags.com: https://www.retromags.com/ Games That Weren't - https://www.gamesthatwerent.com/ Sound Effects by Ethan Johnson of History of How We Play. Copyright Karl Kuras
In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including:Initial workup, which may include laboratory tests and/or imagingLatest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, including considerations for drug–drug interactions Presenters:Martin Witzenrath, MD, FERSMedical DirectorCharite Centrum 12Internal Medicine & DermatologyProfessor and Chair for Respiratory Medicine and Critical CareDepartment of Infectious Disease, Respiratory Medicine and Critical CareCharite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin FranklinCharite – University of BerlinBerlin, GermanyMichele Bartoletti, MD, PhDAssociate Professor of Infectious DiseasesDepartment of Biomedical SciencesHumanitas UniversityPieve Emanuele (MI), ItalyHead of Infectious Diseases UnitIRCCS Humanitas Research HospitalRozzano (MI), Italy Link to full program: https://bit.ly/4gu2gcUDownloadable slides: https://bit.ly/3CGlDBSGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Herkese merhaba, yeni bir Klimik podcast yayını ile birlikteyiz. Hacettepe Üniversitesi ,Tıp Fakültesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalından kıymetli Hocamız Prof. Dr. Murat Akova ile “IDWeek Kongresinden Esintiler” başlıklı yayınımızı dinleyicilerimize sunuyoruz. Hocamız febril nötropeni, immünkompromize hastalardaki infeksiyonlar ve çoklu ilaca dirençli Gram-negatif infeksiyonlar konusunda Türkiye'de ve dünyada öncülük etmektedir. Ayrıca Hocamız, IDSA'in düzenlediği IDWeek toplantısının program komitesinde yer almış, ESCMID'i toplantıda temsil etmiştir. IDWeek üzerine yaptığımız bu heyecan verici ve ufuk açıcı sohbetten dolayı konuğumuza teşekkür ediyoruz, sizlere keyifli dinlemeler diliyoruz.
In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics:Screening recommendationsStrategies to improve HCV screeningHCV testingTreatment goalsStrategies to improve HCV treatment uptakePresenters:Stacey B. Trooskin, MD, PhD, MPHExecutive Medical OfficerMazzoni CenterFaculty, University of PennsylvaniaPerelman School of MedicinePhiladelphia, PennsylvaniaMark S. Sulkowski, MD, FIDSA, FAASLDProfessor of MedicineDirector, Division of Infectious Diseases Johns Hopkins Bayview Medical CenterJohns Hopkins University School of MedicineBaltimore, MarylandRonni MarksFounder/Director, The Hepatitis C Mentor and Support Group (HCMSG)Patient AdvocateNew York, New YorkLink to full program:https://bit.ly/4grbwPT
Sega's Saturn premiere flops, The Game Industry ditches CES for E3 & Nintendo goes for cheap VR These stories and many more on this episode of the VGNRTM! This episode we will look back at the biggest stories in and around the video game industry in July 1994. As always, we'll mostly be using magazine cover dates, and those are of course always a bit behind the actual events. Alex Smith of They Create Worlds is our cohost. Check out his podcast here: https://www.theycreateworlds.com/ and order his book here: https://www.theycreateworlds.com/book Get us on your mobile device: Android: https://www.google.com/podcasts?feed=aHR0cHM6Ly92aWRlb2dhbWVuZXdzcm9vbXRpbWVtYWNoaW5lLmxpYnN5bi5jb20vcnNz iOS: https://podcasts.apple.com/de/podcast/video-game-newsroom-time-machine And if you like what we are doing here at the podcast, don't forget to like us on your podcasting app of choice, YouTube, and/or support us on patreon! https://www.patreon.com/VGNRTM Send comments on Mastodon @videogamenewsroomtimemachine@oldbytes.space Or twitter @videogamenewsr2 Or Instagram https://www.instagram.com/vgnrtm Or https://bsky.app/profile/vgnrtm.bsky.social Or videogamenewsroomtimemachine@gmail.com Links: If you don't see all the links, find them here: https://www.patreon.com/posts/july-1994-116535754 Or check out the complete version of this month's two-parter here: https://www.patreon.com/posts/july-1994-116535754 7 Minutes in Heaven: Streets of Rage 3 Video Version: https://www.patreon.com/posts/7-minutes-in-of-116533647 https://www.mobygames.com/game/11193/streets-of-rage-3/ Corrections: June 1994 Ep - https://www.patreon.com/posts/june-1994-113403594 Ethan's fine site The History of How We Play: https://thehistoryofhowweplay.wordpress.com/ https://www.mobygames.com/group/427/dragons-lair-series-and-versions/ https://en.wikipedia.org/wiki/Entertainment_Software_Association https://en.wikipedia.org/wiki/Comics_Code_Authority Kelsey Lewin did a video on the Extertainment Bike https://www.youtube.com/watch?v=nEuAWIU89sQ The bat was called the Batter-Up Bat https://www.youtube.com/watch?v=6jt3Fa1c_zg I think Tom Kalinske is mixing memories with 1994 Summer CES https://www.youtube.com/watch?v=kc4trf57Rgg https://www.youtube.com/watch?v=sUn7cERhImY https://www.polygon.com/features/2019/6/7/18653968/e3-history-1995-sega-saturn-nintendo-64-playstation-launch https://en.wikipedia.org/wiki/Marcia_Lucas https://www.mobygames.com/game/4572/final-fantasy-ii/ https://www.mobygames.com/game/5202/final-fantasy-iii/ 1994: Japanese console sales drop dramatically JAPANESE MARKET SHARES, Consumer Electronics, July 11, 1994, Section: THIS WEEK'S NEWS, Vol. 34, No. 28 Pg. 15 Weak dollar hurts Japanese exports 95-YEN RATE DEVASTATING FOR MOST EXPORTS, Jiji Press Ticker Service, JULY 14, 1994, THURSDAY https://www.macrotrends.net/2550/dollar-yen-exchange-rate-historical-chart Convertible bonds are big in Japan Issuances of convertible bonds swell Higher Rates Hold Down Volume Of Straight Bonds, The Nikkei Weekly (Japan), July 25, 1994, Section: FINANCE; Pg. 15 Sega's long-term debt rated A3, Japan Economic Newswire, JULY 28, 1994, THURSDAY Semiconductor industry breaks mold Market Place; Are investors in semiconductor stocks living in the past?, The New York Times, July 15, 1994, Friday, Late Edition - Final, Section: Section D; ; Section D; Page 6; Column 3; Financial Desk ; Column 3; Byline: By John Markoff Trip Hawkins leaves EA NEW PCMCIA NEWSLETTER; CMP STAFF TO INTERACTIVE WEEK; EWORLD EYES LARGE ONLINE ACCOUNTS; HAWKINS LEAVES PRIOR, FIRM, Advertising Age, July 04, 1994, Section: Pg. 35 MediaVision premises searched Media Vision Bankruptcy, The New York Times, July 27, 1994, Wednesday, Late Edition - Final, Section: Section D; ; Section D; Page 20; Column 5; Financial Desk ; Column 5; https://archive.org/details/PC-Player-German-Magazine-1994-07/page/n13/mode/2up https://en.wikipedia.org/wiki/Media_Vision#Products Time Warner wants to make ads interactive TIME WARNER INTERACTS WITH MORE THAN ORLANDO DEAL WITH INTERPUBLIC GIVES AGENCY GROUP ACCESS TO VIDEOGAMES, CD-ROMS, Advertising Age, July 04, 1994, Section: Pg. 18, byline: By Scott Donaton ARTERIAL AVENGER VIDEO GAME AVAILABLE FOR COMMUNITY EVENTS/HEALTH FAIRS, PR Newswire, July 7, 1994, Thursday - 10:45 Eastern Time, Section: State and Regional News Video game offers early intervention in the fight against tobacco use; "Rex Ronan -- Experimental Surgeon" goes inside the human body to illustrate the dangers of smoking, Business Wire, July 15, 1994, Friday BATES USA SURVEY IS BULLISH ON INTERACTIVE PREDICTS $7.2 BILLION MARKET WITHIN 10 YEARS;ADS WILL SUBSIDIZE COSTS, Advertising Age, July 11, 1994, Section: Pg. 26, byline: By Scott Donaton Leagas Delaney 'Predator' commercial takes slot in World Cup computer game, Campaign, July 15, 1994, Business and Industry, Section: Pg. 31; https://www.mobygames.com/game/134894/tricky-quiky-games-die-suche-nach-den-verschollenen-seiten/ https://www.mobygames.com/game/6717/helicopter-mission/ https://www.mobygames.com/game/9244/bi-fi-roll-action-in-hollywood/ https://archive.org/details/Aktueller_Software_Markt_-_Ausgabe_1994.07/page/n7/mode/2up https://archive.org/details/Aktueller_Software_Markt_-_Ausgabe_1994.07/page/n9/mode/2up McDonald's launches first FMV ad on AOL McDonald's to Post Golden Arches Along Information Superhighway, Wall Street Journal (3 Star, Eastern (Princeton, NJ) Edition), July 21, 1994, Business and Industry, Section: Pg. B7; Vol. 224; No. 14; ISSN: 0099-9660 HBO and Warner go interactive Home Box Office and Warner Music Group join Michael Nash in forming new multimedia partnership, Business Wire, July 12, 1994, Tuesday GTE goes Interactive BITS AND PIECES, TELECOMWORLDWIRE, July 1, 1994 Jim Henson goes interactive Muppets' hand in interactivity, The Hollywood Reporter, July 21, 1994, Thursday, Byline: Scott Hettrick Time Mirror goes interactive Rose CEO of TM Multimedia, The Hollywood Reporter, July 27, 1994, Wednesday Nick Nicholas invests in VR Media Industry Visionary, Nick Nicholas, Becomes Major Investor in Zombie Inc., Business Wire, July 15, 1994, Friday https://www.mobygames.com/company/1266/zombie-studios-inc/games/ Havas and Sony join forces Alliance Havas-Sony dans l'edition electronique, Echos, July 21, 1994 Sony, Havas playing games, The Hollywood Reporter, July 22, 1994, Friday, Byline: Pia Farrell http://jolt.law.harvard.edu/articles/pdf/v12/12HarvJLTech561.pdf France expands multimedia services Media Futures: The French connection - John Ridding looks at the country's growing multimedia businesses / The world's superhighways, Financial Times (London,England), July 4, 1994, Monday, Section: Pg. 15, Byline: By JOHN RIDDING Telecom deregulation hits Japan Barrier lowered between cable-TV, phone firms, The Nikkei Weekly (Japan), July 4, 1994, Section: INDUSTRY DIGEST; Pg. 9, Byline: BY NORRI KAGEKI Staff writer IDSA and SPA try to find common ground IDSA AND SPA MEET ON RATINGS, Consumer Electronics, July 11, 1994, Section: THIS WEEK'S NEWS, Vol. 34, No. 28 Pg. 13 No Headline In Original, Consumer Electronics, July 18, 1994, Section: NOTEBOOK; Vol. 34, No. 29; Pg. 14 IDSA and SPA fail to find common ground 2 GAME RATING SYSTEMS, Consumer Electronics, July 25, 1994, Section: THIS WEEK'S NEWS, Vol. 34, No. 30 Competing rating systems revealed Ratings Symbols Unveiled for Computer, Video Games, The Associated Press, July 28, 1994, Thursday, AM cycle, Section: Business News, Byline: By JEANNINE AVERSA, Associated Press Writer https://legacy.3drealms.com/tech/rsac.html https://legacy.3drealms.com/tech/esrb.html Lieberman and Kohl weigh in on systems Ratings Symbols Set for Computer, Video Games, The Associated Press, July 29, 1994, Friday, PM cycle, Section: Business News, Byline: By JEANNINE AVERSA, Associated Press Writer TESTIMONY REGARDING THE VIDEO GAME RATING ACT OF 1994 SUBMITTED BY MARK TRAPHAGEN - COUNSEL SOFTWARE PUBLISHERS ASSOCIATION SOFTWARE PUBLISHERS ASSOCIATION JOINT HEARING OF THE SENATE GOVERNMENTAL AFFAIRS SUBCOMMITTEE ON REGULATION AND GOVERNMENT INFORMATION AND THE SENATE JUDICIARY SUBCOMMITTEE ON JUVENILE JUSTICE, Federal News Service, JULY 29, 1994, FRIDAY German voluntary game ratings begin https://archive.org/details/Aktueller_Software_Markt_-_Ausgabe_1994.07/page/n9/mode/2up https://usk.de/ Nintendo signs onto CESI NINTENDO SIGNS FOR CES INTERACTIVE '95, Consumer Electronics, July 4, 1994, Section: THIS WEEK'S NEWS, Vol. 34, No. 27; Pg. 13 IDSA AND SPA MEET ON RATINGS, Consumer Electronics, July 11, 1994, Section: THIS WEEK'S NEWS, Vol. 34, No. 28 Pg. 13 ISDA chooses E3 New L.A. interactive expo lines up Sony, Sega, IDSA; E3 will take on CES and VSDA next spring, The Hollywood Reporter, July 18, 1994, Monday, Byline: Scott Hettrick IDSA ENDORSES E3 SHOW, SAME DATES AS CES INTERACTIVE, Consumer Electronics, July 18, 1994, Section: THIS WEEK'S NEWS; Vol. 34, No. 29; Pg. 10 Namco consolidates coin op subsidiaries Play Meter, July 1994, pg. 14 Time Warner licenses Jaguar ATARI CORPORATION AND TIME WARNER INTERACTIVE INC. JAGUAR DEAL, PR Newswire, July 12, 1994, Tuesday - 07:53 Eastern Time, Section: Financial News, Dateline: SUNNYVALE, Calif., July 12 https://system16.com/hardware.php?id=778 Bally breaks up Play Meter, July 1994, pg. 28 Recommended Links: The History of How We Play: https://thehistoryofhowweplay.wordpress.com/ Gaming Alexandria: https://www.gamingalexandria.com/wp/ They Create Worlds: https://tcwpodcast.podbean.com/ Digital Antiquarian: https://www.filfre.net/ The Arcade Blogger: https://arcadeblogger.com/ Retro Asylum: http://retroasylum.com/category/all-posts/ Retro Game Squad: http://retrogamesquad.libsyn.com/ Playthrough Podcast: https://playthroughpod.com/ Retromags.com: https://www.retromags.com/ Games That Weren't - https://www.gamesthatwerent.com/ Sound Effects by Ethan Johnson of History of How We Play. Copyright Karl Kuras
In 2020, with funding from CDC, IDSA launched the Real-Time Learning Network, a website that provided timely information about COVID-19 pandemic to clinicians and the public. In this episode, medical editors of the Real-Time Learning Network recounts their experiences building the project from the ground up and lessons learned for the future.
Nesse episódio conversamos sobre pontos importantes de infecção e resistência bacteriana por Gram negativos. Depois de assistí-lo você vai entender um pouco mais sobre infecções por bactérias MDR (Multi Droga Resistente como KPC e outras Betalactamases). Em um mundo que cada vez mais vivemos o conceito de "Onehealth" e que todas as nossas ações importam, você precisa entender a importância desses patógenos tanto em ambientes hospitalares quanto fora dele. Para mais conteúdo sobre infectologia acesse: https://www.infectologiapro.com.br/ Referências Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Boletim Epidemiológico - Volume 55 - nº 02 Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2024/boletim-epidem-vol-55-n-2/view Pfizer Brasil Bula Medicamentos TORGENA® (ceftazidima + avibactam)Disponível em:https://www.pfizer.com.br/bulas/torgena. Acessado em 03/09/2024 Peleg, Anton Y., and David C. Hooper. “Hospital-Acquired Infections due to Gram-Negative Bacteria.” New England Journal of Medicine, vol. 362, no. 19, 13 May 2010, pp. 1804–1813, www.ncbi.nlm.nih.gov/pmc/articles/PMC3107499/ Infectious Diseases Society of America. IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Disponivel: https://www.idsociety.org/practice-guideline/amr-guidance/ acessado 03/09/2024 PP-UNP-BRA-5649 | Setembro/2024
Dies ist der zweite Teil über multiresistente Erreger, die wir anhand der IDSA Guidance on the Treatment of Antimicrobial Resitant Gram-Negativ Infections besprechen. Dieses Mal geht es um Pseudomonas aeruginosa, Acinetobacter baumanii und Stenotrophomonas maltophilia. Wir erklären die unterscheidlichen Resistenzmechanismen, diskutieren deren Folgen und Therapiemöglichkeiten. Links: IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negativ … „Infektiopod #87: Multiresistente gramnegative Erreger – Teil 2“ weiterlesen
In this episode of HIV unmuted, host Juan Michael Porter II sits down with Jeanne Marrazzo, the Director of the National Institute of Allergy and Infectious Diseases (NIAID), in a conversation that goes beyond the headlines and deep into the heart of HIV research and advocacy. Dr Marrazzo, a leader with decades of experience in infectious disease research, shares her inspiring journey from her roots in Scranton, Pennsylvania, to her groundbreaking work in HIV prevention and care. Through this intimate conversation, listeners will discover what drives Dr. Marrazzo's commitment to equity, diversity and community-centered research, and how her personal and professional experiences shape her vision for the future of HIV science. From the challenges of addressing global health inequities to the optimism surrounding new HIV prevention methods, Dr Marrazzo offers valuable insights into the importance of inclusive messaging, the power of collaboration, and why putting people first remains at the core of her mission. Tune in to hear how Jeanne Marrazzo plans to navigate the evolving landscape of global health as she leads NIAID into a new era, and why she believes that hope, innovation, and community are key to overcoming the ongoing challenges in the HIV response. Meet our guest: Jeanne Marrazzo Jeanne Marrazzo, MD, MPH, FACP, FIDSA, is the Director of NIAID at the U.S. National Institutes of Health (NIH), where she oversees a USD 6.3 billion budget that supports research to advance understanding, diagnosis and treatment of infectious, immunologic and allergic diseases. She was previously the C. Glenn Cobbs Endowed Chair and Director of Infectious Diseases at the University of Alabama at Birmingham Heersink School of Medicine. She is a Fellow of the American College of Physicians and the Infectious Diseases Society of America (IDSA), and was Treasurer of the IDSA from 2021 to 2023, having served on the board since 2018. She researches the vaginal microbiome, sexually transmitted infections and HIV pre-exposure prophylaxis. She has had leadership roles in the NIH HIV Prevention Trials Network and the Infectious Diseases Clinical Research Consortium. She was a leading voice in communicating science during the COVID-19 pandemic. Meet our host: Juan Michael Porter II Juan Michael Porter II is a health journalist, HIV advocate, culture critic, educator and the host of HIV unmuted, the IAS podcast. He is the Senior Editor of TheBody.com and TheBodyPro – and the first person openly living with HIV to hold the position. Juan Michael's reportage combines data dives, personal narratives and policy analyses to address the real-world consequences of ever-shifting legislation on people's health outcomes. He has written for the Public Broadcasting Service, SF Chronicle, Philadelphia Inquirer, Christian Science Monitor, NY Observer, TDF Stages, Playbill, American Theatre, Time Out NY, Queerty, Anti-Racism Daily, Positively Aware, Documentary Magazine, SYFY Wire, Scholastic and Dance Magazine.
In this week's Gaming Fun Fact we explored the origins of E3, as video games matured from a simple tent at CES, to a well organized and professionally represented industry. Previously considered just a kid's toy, video games weren't given a proper platform to showcase their hardware and software. However, after the Senate started taking interest in violent games such as Mortal Kombat, the IDSA (now ESA), ESRB, and E3 were eventually all formed to give games a place to interact on a political and public relations level. PlayStation State of Play September 2024 just took place and was loaded with announcements for not only PS5 but also PS VR2. Some key game announcements & showcases included the Ghost of Tsushima sequel - Ghost of Yotei, Monster Hunter Wilds, and Horizon Zero Dawn Remastered. With the PS5 Pro available for pre-order and a short hardware showcase behind us, many gamers were left wondering which games would be taking advantage of the PS5 Pro's power. Sony has released a rather large list of games, both old and new, that will be receiving PS5 Pro enhancements including: Ratchet & Clank: Rift Apart, Rise of the Ronin, Assassin's Creed Shadows, and much more.
Episode Notes In this episode, Dr. Jeannette Bouchard and guest Dr. Emily Heil walk listeners through key updates to the IDSA Resistant Gram-negative Guidance and what may be most pertinent for our community partners. The materials reviewed today can be found here: https://www.idsociety.org/practice-guideline/amr-guidance/#UpdateHistory For more information about DASON, please visit: https://dason.medicine.duke.edu/
In this episode of the Trust Issues podcast, host David Puner sits down with Jeff Reich, Executive Director of the Identity Defined Security Alliance (IDSA), a nonprofit that provides vendor-neutral guidance on identity-centric security strategies to help organizations reduce the risk of identity-related attacks. They explore the evolution of digital identity, discussing how it has transformed from simple identifiers to complex, multifaceted digital identities for both humans and machines. In today's threat landscape, the number and types of identities, attack methods and environments have dramatically increased, making it more challenging to secure identities. Jeff discusses the challenges and efforts in creating sustainable, interoperable digital identity hubs for cross-border applications, the future of digital passports and the importance of encryption and multi-factor authentication (MFA) for securing sensitive data. The conversation also highlights the significance of thought leadership and maintaining a vendor-agnostic approach in identity security.
Unfortunately, there simply isn't a one-size-fits-all treatment protocol for patients infected with Lyme disease and/or co-infections. This is why it's critical for physicians treating Lyme disease to invest time with patients, thoroughly understand their medical history, and closely monitor symptoms and treatment response. With that in mind, there are currently two different treatment approaches for Lyme disease. The Infectious Disease Society of America (IDSA) and the International Lyme and Associated Diseases Society (ILADS) have each published their own set of evidence-based treatment guidelines. IDSA guidelines recommend a short course of antibiotics, typically 14 to 30 days. IDSA argues that the Borrelia burgdorferi bacteria do not persist in a patient beyond this timeframe and that lingering symptoms are the result of an ongoing immune response and not an active infection. It also cites scientific evidence claiming treatments beyond 30 days are ineffective, unnecessary, and even dangerous. IDSA physicians will stop treatment after 30 days, even if symptoms remain. They advise an additional 30 days of treatment recommended for patients with Lyme arthritis. On the contrary, ILADS offers its own scientific data to show that a additional treatment with antibiotics is required to eradicate the bacteria. ILADS recognizes that a month of treatment may be sufficient for patients in the acute stage of Lyme disease, but in cases where the spirochete has disseminated and the disease has advanced, a 30-day treatment regimen is inadequate. ILADS guidelines recommend additional antibiotics until a patient's symptoms have been resolved. Treating Lyme disease in its advanced stage can be complicated based on the complexity of the organism itself, differences in each patient's immune system, the length of time infected, and the possible presence of other co-infections transmitted by the same tick. There are several choices in treating Lyme disease, which include oral, intravenous, and intramuscular antibiotic options. Other options may include sequential antibiotic therapy, higher doses of antibiotics, taking antibiotics for a longer period of time, a combination of antibiotics, retreatment, as well as diagnosing and treating co-infections. Some specific antibiotics used in treating Lyme disease are doxycycline, minocycline, amoxicillin, cefuroxime, azithromycin, and clarithromycin. Other tests include measures of blood counts, chemistries, liver function tests, ANA, dsDNA, RF, TSH, free T3, free T4, ESR may be helpful at ruling out other conditions. Referral to specialist might help to rule out other conditions. I find shared decision with my patient helpful. I also find follow-up helpful to assess my patient's response to treatment to rule out other conditions. There are additional protocols that may also aid in treating Lyme disease, such as avoiding alcohol, simple and processed sugars, exercising as tolerated, counseling for a Jarisch-Herxheimer reaction, managing symptoms, monitoring and reducing the risk of an adverse event, and reducing stress. However, there is a chance of side effects such as Clostridium difficile-associated diarrhea (CDAD). Probiotic have been prescribed with the hope of reducing the risk of developing CDAD.
Guest: Jeff Reich, Executive Director, Identity Defined Security Alliance [@idsalliance]On LinkedIn | https://www.linkedin.com/in/jreich/On Twitter | https://twitter.com/JeffReichCSO____________________________Hosts: Sean Martin, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining CyberSecurity Podcast [@RedefiningCyber]On ITSPmagazine | https://www.itspmagazine.com/sean-martinMarco Ciappelli, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining Society PodcastOn ITSPmagazine | https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/marco-ciappelli____________________________Episode NotesWelcome to this pre-event episode of On Location, where we're diving into what's to come at Identity Week Americas, happening September 11th and 12th, 2024, at the Washington Convention Center in D.C. Although I won't be on-site, Jeff—who leads the Identity Defined Security Alliance (IDSA)—gave me the inside scoop on why this event is one you can't afford to miss.Our conversation ranges from the critical role of digital identities and payments, to the pressing challenges facing the identity landscape today. Jeff shared insights on the panels he'll be participating in, like Interoperable Digital Identities and The Future of Payments, giving a preview of the big discussions that will take place at the event.We even touched on more serious global issues, such as the plight of refugees who lack identification, and how Identity Week is working toward solutions that can have a real impact. On top of that, the SIDI HUB Summit will run alongside the event, focusing on creating a standardized, globally recognized digital identity system.With Identity Week happening across multiple continents—from the Americas to Europe and Asia—the need for international collaboration has never been clearer. Jeff's vision for a globally interoperable identity system is ambitious, but the starting point is simple: practical steps like multi-factor authentication and building awareness about identity security.As we look forward to the event, Jeff also mentioned that there might still be some passes available for those interested in attending. Whether you're in the public sector, tech, or simply passionate about identity solutions, this event is your chance to get involved in shaping the future.Stay tuned for more coverage, and thanks for joining me on this pre-event journey as we explore what's in store at Identity Week Americas.Be sure to follow our Coverage Journey and subscribe to our podcasts!____________________________This Episode's SponsorsHITRUST: https://itspm.ag/itsphitweb____________________________Catch all of our event coverage: https://www.itspmagazine.com/technology-cybersecurity-society-humanity-conference-and-event-coverageOn YouTube:
Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections. The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.HostJen Moulton, BSPharmPresident, CEimpactGuests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD,BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organismsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN: 0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.
Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections. The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.Guests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organisms Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN: 0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
Welcome! Today, we're exploring the key milestones in Lyme disease research and treatment.I had a 57-year-old patient who remained chronically ill after being diagnosed and treated for Lyme disease. He didn't realize that a persistent tick-borne infection could explain his chronic illness. He was treated with a combination of azithromycin and atovaquone for the persistent infection, and today, he is doing well.He was surprised that, despite the milestones in Lyme disease research, he wasn't aware that a persistent infection could lead to his chronic illness. So, let's take a closer look at these milestones.1. 1977: Discovery of Lyme DiseaseOur story begins in 1977 in Lyme, Connecticut. A cluster of children and adults were diagnosed with what was initially thought to be juvenile rheumatoid arthritis. This event marked the identification of Lyme disease as a distinct illness and the start of modern Lyme disease awareness."2. 1982: Discovery of the Bacterium Responsible for Lyme DiseaseIn 1982, Dr. Willy Burgdorfer identified Borrelia burgdorferi, the bacterium responsible for Lyme disease. This discovery was a major milestone, enabling more precise identification and treatment of the disease. 3. 1990: Recognition of Chronic Lyme DiseaseBy 1990, chronic Lyme disease, with its long-term and persistent symptoms, was officially recognized. This led to more comprehensive treatment protocols and increased awareness of the disease's chronic nature.4. 1995: Discovery of Babesia microtiIn 1995, Babesia microti was identified as a co-infection transmitted by the same ticks that carry Lyme disease. This highlighted the complexity of tick-borne illnesses and the need for integrated treatment approaches. 5. 2000: Publication of IDSA and ILADS GuidelinesThe year 2000 saw the publication of treatment guidelines by both the Infectious Disease Society of America (IDSA) and the International Lyme and Associated Diseases Society (ILADS). These guidelines showcased different approaches to treating Lyme disease, marking another significant milestone. 6. Ongoing Research and Future Milestones Research is ongoing, and we look forward to future milestones that could lead to breakthroughs in diagnosis and treatment. Studies on biofilms, persisters, and tick-borne co-infections may enable doctors to develop treatment plans that significantly improve patient outcomes.ConclusionUnderstanding these milestones helps us appreciate the progress made in the fight against Lyme disease. With continued research and dedication, we move closer to effective management and potential cures. Thank you for watching, and stay tuned for more insights on Lyme disease."
Nintendo and Sega financials dissapoint Sony gets ready for NextGen Venture money goes ga-ga over silliwood These stories and many more on this episode of the VGNRTM! This episode we will look back at the biggest stories in and around the video game industry in May 1994. As always, we'll mostly be using magazine cover dates, and those are of course always a bit behind the actual events. Alex Smith of They Create Worlds is our cohost. Check out his podcast here: https://www.theycreateworlds.com/ and order his book here: https://www.theycreateworlds.com/book or get it in the Humble Bundle here: https://www.humblebundle.com/books/game-programming-taylor-francis-books Get us on your mobile device: Android: https://www.google.com/podcasts?feed=aHR0cHM6Ly92aWRlb2dhbWVuZXdzcm9vbXRpbWVtYWNoaW5lLmxpYnN5bi5jb20vcnNz iOS: https://podcasts.apple.com/de/podcast/video-game-newsroom-time-machine And if you like what we are doing here at the podcast, don't forget to like us on your podcasting app of choice, YouTube, and/or support us on patreon! https://www.patreon.com/VGNRTM Send comments on Mastodon @videogamenewsroomtimemachine@oldbytes.space Or twitter @videogamenewsr2 Or Instagram https://www.instagram.com/vgnrtm Or videogamenewsroomtimemachine@gmail.com Links: If you don't see all the links, find them here: https://www.patreon.com/posts/110575391 7 Minutes in Heaven: Rebel Assault (SegaCD) Video Version: https://www.patreon.com/posts/7-minutes-in-may-110535204 https://www.mobygames.com/game/272/star-wars-rebel-assault/ https://en.wikipedia.org/wiki/Star_Wars:_Rebel_Assault Corrections: April 1994 Ep - https://www.patreon.com/posts/april-1994-107563816 Ethan's fine site The History of How We Play: https://thehistoryofhowweplay.wordpress.com/ 1994-05: Console market in a slump Edge 8, May 1994 pg. 18 Panasonic tries to save 3DO Edge 8, May 1994 pg. 16 https://x.com/blakejharrisNYC/status/1168364212139307008 Nintendo loosens minimum cart order rules in Japan "Nintendo easing iron grip on programmers Video-Game Giant Halves Minimum Cartridge Order, The Nikkei Weekly (Japan), May 2, 1994, Section: INDUSTRY; Pg. 8 Nintendo stock keeps dropping Nintendo shares no fun in 1994 - Emiko Terazono on reaction to the gamemaker's revised forecasts, Financial Times (London,England), May 6, 1994, Friday, London; Section: World Stock Markets; Pg. 39, Byline: By EMIKO TERAZONO Nintendo is a top earner TOYOTA RETURNS AS NO.1 INCOME EARNER IN JAPAN, Jiji Press Ticker Service, MAY 18, 1994, WEDNESDAY,Dateline: TOKYO, MAY 18 Sega profits plunge Sega Enterprises reports 22.7% pretax profit fall, Japan Economic Newswire, MAY 19, 1994, THURSDAY Sony Computer Entertainment of America formed https://www.nytimes.com/1994/05/19/business/company-news-sony-starts-a-division-to-sell-game-machines.html?searchResultPosition=1 3DO shares collapse https://www.nytimes.com/1994/05/21/business/company-news-shares-of-3do-fall-by-another-18.html Nintendo profits plunge... more Nintendo suffers first profit decline in 10 years,Japan Economic Newswire,MAY 23, 1994, MONDAY Nintendo reports solid earnings despite strong yen; outlines exciting new software plans for 1994, Business Wire, May 23, 1994, Monday THQ sales collapse T-HQ announces first-quarter results, Business Wire, May 11, 1994, Wednesday Absolute Entertainment reports first quarter results, Business Wire, May 10, 1994, Tuesday EA/Broderbund merger collapses No Headline In Original, Consumer Electronics, May 9, 1994, Section: NOTEBOOK, Vol. 34, No. 19 https://archive.org/details/Electronic-Games-1994-05/page/n21/mode/1up?view=theater https://www.smoliva.com/2024/08/07/what-the-learning-company-taught-us-about-the-history-of-computer-software/ Davidson & Associates buys Chaos Studios https://archive.org/details/Electronic-Games-1994-05/page/n17/mode/1up?view=theater Fox Interactive launches Twentieth Century Fox establishes new interactive multimedia division; new division to utilize News Corp. resources, Business Wire, May 20, 1994, Friday Fall of Park Place profiled https://archive.org/details/Electronic-Games-1994-05/page/n9/mode/1up?view=theater Forbes profiles Id Profits from the underground, Forbes, May 9, 1994,Section: COMPUTERS/COMMUNICATIONS INTERACTIVE MEDIA; Parameters; Commentary; Pg. 176, Byline: BY ANDREW J. KESSLER AOU lacks premieres Edge 8, May 1994 pg. 8 Saturn to become an arcade Titan Edge 8, May 1994 pg. 7 https://segaretro.org/Sega_Titan_Video Play Meter, May 1994, pg. 16 https://segaretro.org/Batman_Forever_(arcade) Namco consolidates Play Meter, May 1994, pg. 12 Atari links up with Bally Edge 8, May 1994 pg. 13 Virtuality goes to Japan British high-tech game maker to enter Japan, Japan Economic Newswire, MAY 6, 1994, FRIDAY Https://en.wikipedia.org/wiki/Wakayama_Marina_City#Minor_attractions Play Meter May 1994, pg. 251 Sony delivers devtools Edge 8, May 1994 pg. 13 Sega disses Jupiter for Mars Edge 8, May 1994 pg. 6 DMA signs up with Nintendo Nintendo and U.K.-based DMA design announce Project Reality agreement; 64-bit home games to debut in fall 1995, Business Wire, May 2, 1994, Monday Nintendo smashes myths https://archive.org/details/GamePro_Issue_058_May_1994/page/n31/mode/1up?view=theater Howard Lincoln to deliver CES keynote Playthings May 1994, pg. 22 Laseractive drops price Pelican Brief,' Pakula Classics Due From Warner, Billboard, May 7, 1994, Section: HOME VIDEO; Laser Scans; Pg. 96, Byline: by Chris McGowan https://youtu.be/qSdfj5O-N1Q?si=Wx7ZJ_Yvc6MafKSK NEC taps out of 3D race Edge 8, May 1994 pg. 14 NEC gives PC Engine another lease on life Edge 8, May 1994 pg. 15 Sigma Designs to bring Jaguar to PC Sigma To Make Atari Jaguar Titles Run On PC, Newsbytes, May 3, 1994, Tuesday Reinventing the Z-Machine is apparently Rocket Science Platform battle, Forbes, May 9, 1994, Section: COMPUTERS/COMMUNICATIONS INTERACTIVE MEDIA; Pg. 168, Byline: By Nikhil Hutheesing Silliwood gold rush continues... Sillywood, Forbes, May 9, 1994, Section: MANAGEMENT/CORPORATE STRATEGIES; Pg. 46, Byline: By Lisa Gubernick and Nikhil Hutheesing Rocket Science takes off with funding from Sega Enterprises and Bertelsmann Music Group; 10-month-old start up attracts major corporate investors, Business Wire, May 18, 1994, Wednesday Penn & Teller sign up with Absolute PENN & TELLER, THOSE 'BAD BOYS OF MAGIC,' MAKE THEIR VIDEO GAME DEBUT WITH ABSOLUTE ENTERTAINMENT, Business Wire, May 19, 1994, Thursday CD-i gets John Cleese No Headline In Original, Consumer Electronics, May 2, 1994, Section: NOTEBOOK; Vol. 34, No. 18; Pg. 13 Argonaut working on 3D accelerator Edge 8, May 1994 pg. 19 https://en.wikipedia.org/wiki/ARC_(processor) Sirius introduces 5 ft. 10 pack CD-ROM publishers unite-users benefit; introductory 5 ft. 10 Pak. flies from shelves, Business Wire, May 3, 1994, Tuesday https://worldroms.com/5-ft-10-pak-volume-1-details.html Commodore advertises CD32.. in the US? https://archive.org/details/GamePro_Issue_058_May_1994/page/n10/mode/1up?view=theater Commodore developing RISC CPU https://archive.org/details/amiga-computing-magazine-073/page/n33/mode/2up Commodore shows off CD drive at Cebit Amiga Format 59, pg. 24 C64S launches https://archive.org/details/64er_1994_05/page/n35/mode/1up https://www.c64-wiki.de/wiki/C64s CPC emulation comes to PC Amstrad Action 104, pg. 8 https://cpc-emu.org/news.html Sega Channel to launch in Japan Sega to provide to provide videogames on cable TV, Report From Japan, May 3, 1994,Section: Business Silicon Graphics founder teams up with Mosaic devs https://www.nytimes.com/1994/05/07/business/new-venture-in-cyberspace-by-silicon-graphics-founder.html?searchResultPosition=8 Lexis Nexis to get SEC filings https://www.nytimes.com/1994/05/11/business/company-news-agreement-to-utilize-sec-data.html?searchResultPosition=18 Computer biz to dominate Akihabara Akihabara shifting to 'computer town' amid recession, Japan Economic Newswire, MAY 4, 1994, WEDNESDAY, Byline: Hisa Miyatake Rewritable carts coming to Blockbuster Sega and NewLeaf to test video game software delivery system that eliminates retailer stock-outs, Business Wire, May 31, 1994, Tuesday https://segaretro.org/Game_Factory Copying goes legit in the UK with EDOS https://commodore.software/downloads?task=download.send&id=15005:commodore-format-issue-44&catid=721 pg. 22 https://blog.amigaguru.com/edos-the-software-on-demand-of-the-80s/ http://amigaguru.com/Games/EDOS_MAGAZINE_1991-1992__ENGLISH.pdf https://www.computinghistory.org.uk/det/63955/EDOS/ https://find-and-update.company-information.service.gov.uk/company/SC121687/filing-history?page=1 Psytronik keeps the C64 alive https://commodore.software/downloads?task=download.send&id=15005:commodore-format-issue-44&catid=721 pg. 8 https://www.psytronik.net/ Lieberman picks IDSA over SPA SENATORS WARN ON GAME RATINGS, Consumer Electronics, May 9, 1994, Section: THIS WEEK'S NEWS, Vol. 34, No. 19 Alpex faces off against Nintendo in court https://www.nytimes.com/1994/05/16/business/patents-108332.html?searchResultPosition=30 https://itlaw.fandom.com/wiki/Alpex_Computer_v._Nintendo Japanese Copyright change scuttled https://www.nytimes.com/1994/05/19/business/japan-likely-to-retain-curb-on-software-raiding.html?searchResultPosition=33 Jean-Claude Van Damme to headline Street Fighter movie https://archive.org/details/GamePro_Issue_058_May_1994/page/n171/mode/1up?view=theater Multimedia-centric horror film captures Zeitgeist https://www.nytimes.com/1994/05/01/movies/film-taking-the-children-like-your-mom-said-beware-sweet-serial-ads-931985.html?searchResultPosition=4 Virgin to release Music compilation CD Billboard previews music's digital future In The Brave New Technological World, Music Uses And Publishing Possibilities Seem Endless, Billboard, May 7, 1994, Section: MUSIC PUBLISHING; Spotlight; Pg. 76, Byline: BY MARILYN A. GILLEN Green Jelly wants to ooze all over multimedia Green Jelly's Land Of Ooz: Zoo Act Opens Vid Facility, Billboard,May 21, 1994,Section: Pg. 1,Byline: BY DEBORAH RUSSELL Recommended Links: The History of How We Play: https://thehistoryofhowweplay.wordpress.com/ Gaming Alexandria: https://www.gamingalexandria.com/wp/ They Create Worlds: https://tcwpodcast.podbean.com/ Digital Antiquarian: https://www.filfre.net/ The Arcade Blogger: https://arcadeblogger.com/ Retro Asylum: http://retroasylum.com/category/all-posts/ Retro Game Squad: http://retrogamesquad.libsyn.com/ Playthrough Podcast: https://playthroughpod.com/ Retromags.com: https://www.retromags.com/ Games That Weren't - https://www.gamesthatwerent.com/ Sound Effects by Ethan Johnson of History of How We Play. Copyright Karl Kuras 30 years ago: #Nintendo and #Sega financials disappoint, #Sony gets ready for NextGen & Venture money goes ga-ga over #Silliwood These stories and many more on the VGNRTM! https://www.patreon.com/posts/110575391
IDSA Board member Mati Hlatshwayo Davis, MD, MPH, FIDSA, discusses the importance of advocacy, including how IDSA and HIVMA members can get involved, with chair and vice chair of IDSA's advocacy captain subcommittee, Rachel Bender Ignacio, MD, MPH, FIDSA, and Kinna Thakarar, DO, MPH, FIDSA, as well as IDSA senior vice president of public policy and government relations, Amanda Jezek, and HIVMA executive director, Andrea Weddle. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/
Google agrees to delete billions of user records. NIST addresses the NVD backlog. India rescues hundreds of citizens from scam jobs in Cambodia. The UK and US agree to collaborate on AI safety. The FTC tracks an explosion in impersonation fraud. A PandaBuy breach exposes over 1.3 million customers. Prudential Financial informs over 36,000 customers of a data breach. A look at safeguarding sensitive data. Our guest is Jeff Reich, Executive Director of the Identity Defined Security Alliance (IDSA), with insights on identity security best practices. A dash of curiosity reveals a hotel chain vulnerability. Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Guest Jeff Reich, Executive Director of the Identity Defined Security Alliance (IDSA), sharing insights on identity security best practices, identity and access sprawl, and how Generative AI is helping and hurting identity management. The IDSA's Identity Management Day 2024 is coming up on April 9, 2024. Selected Reading Google agreed to erase billions of browser records to settle a class action lawsuit (Security Affairs) Vulnerability database backlog due to increased volume, changes in 'support,' NIST says (The Record) India rescues 250 citizens enslaved by Cambodian cybercrime gang (Bleeping Computer) The US and UK are teaming up to test the safety of AI models (Engadget) Impersonation Scams Net Fraudsters $1.1bn in a Year ( Infosecurity Magazine) PandaBuy data breach allegedly impacted +1.3M customers (Security Affairs) Prudential Financial Data Breach Impacts 36,000 (SecurityWeek) How to bridge the gap between the IT and legal staffs to better combat insider risk (SC Media) IBIS hotel check-in terminal keypad-code leakage (Pentagrid AG) Share your feedback. We want to ensure that you are getting the most out of the podcast. Please take a few minutes to share your thoughts with us by completing our brief listener survey as we continually work to improve the show. Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at cyberwire@n2k.com to request more info. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © 2023 N2K Networks, Inc.
Guest: ✨ Jeff Reich, Executive Director, Identity Defined Security Alliance [@idsalliance]On LinkedIn | https://www.linkedin.com/in/jreich/On Twitter | https://twitter.com/JeffReichCSO____________________________Host: Marco Ciappelli, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining Society PodcastOn ITSPmagazine | https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/marco-ciappelli_____________________________This Episode's SponsorsBlackCloak
In this episode, hosts Jim McDonald and Jeff Steadman welcome Jeff Reich, Executive Director at the Identity Defined Security Alliance (IDSA), back to the IDAC Podcast for his third appearance. The main topic of discussion is Identity Management Day 2024. They deep dive into what's new with the IDSA, the exciting content to expect on Identity Management Day, and Jeff Reich shares his rapid-fire thoughts on AI, the Change Healthcare Cyberattack, converged identity vs. best of breed, and the top trends for identity tech firms. Connect with Jeff Reich: https://www.linkedin.com/in/jreich/ Learn more about the IDSA: https://www.idsalliance.org/ Identity Management Day 2024: https://www.idsalliance.org/event/identity-management-day-2024/ Connect with us on LinkedIn: Jim McDonald: https://www.linkedin.com/in/jimmcdonaldpmp/ Jeff Steadman: https://www.linkedin.com/in/jeffsteadman/ Visit the show on the web at idacpodcast.com and follow @IDACPodcast on Twitter.
Dr. Lisa Law and Dr. Randy Taplitz share the latest evidence-based recommendations from ASCO on vaccines in adults with cancer. They discuss recommended routine preventative vaccinations, additional vaccinations and revaccinations for adults undergoing HSCT, CD19 CAR-T treatment, or B cell-depleting therapy, guidance for adults with cancer traveling outside the U.S., and recommendations for vaccination of household and close contacts of adults with cancer. Dr. Law and Dr. Taplitz also share their insights on the guideline, including the importance of this guideline for adults with cancer and their clinicians, future advances in research, and current unmet needs. Read the full guideline, “Vaccination of Adults with Cancer: ASCO Guideline” at www.asco.org/supportive-care-guidelines. TRANSCRIPT This guideline, clinical tools, and resources are available at http://www.asco.org/supportive-care-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO.24.00032 The ASCO Specialty Societies Advancing Adult Immunization (SSAAI) Project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award to the Council of Medical Specialty Societies (CMSS) (with 100 percent funded by CDC/HHS). The contents are those of the authors and do not necessarily represent the official views of nor endorsement, by CDC/HHS or the U.S. Government. Brittany Harvey: Hello, and welcome to the ASCO Guidelines Podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today, I am interviewing Dr. Lisa Law from Kaiser Permanente and Dr. Randy Taplitz from City of Hope Comprehensive Cancer Center, authors on “Vaccination of Adults with Cancer: ASCO Guideline.” Thank you for being here, Dr. Law and Dr. Taplitz. Dr. Lisa Law: Thank you. Dr. Taplitz: Thank you, Brittany. Brittany Harvey: Before we discuss this guideline, I'd like to take note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Taplitz and Dr. Law, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then, to dive into the content, here first, Dr. Taplitz, can you provide a general overview of both the scope and purpose of this guideline on vaccination of adults with cancer? Dr. Randy Taplitz: Yes, so people with cancer often experience a compromised immune system due to a variety of factors. This includes chronic inflammation, impaired or decreased function of the hematopoietic system, and treatments that compromise their immune function. Because of this, people with cancer are at a higher risk for infection, including with vaccine-preventable diseases. Also, response to vaccines in patients with cancer may well be affected by this underlying immune status, and their anticancer therapy, as well as the severity of the underlying malignancy. The purpose of vaccination in this group of patients is to prevent infection or to attenuate the severity of the disease when infection cannot be fully prevented. This ASCO review builds on a 2013 guideline by the Infectious Diseases Society of America, or IDSA, and uses what's called a systematic literature review of 102 publications between 2013 and 2023. This includes 24 systematic reviews, 14 randomized clinical trials, and 64 non-randomized studies. The largest body of evidence in these studies, not surprisingly, addresses COVID vaccines on the efficacy and safety of vaccines used by adults with cancer or their household contacts. ASCO convened an expert panel to review this evidence and formulate recommendations for vaccinations in this population. Brittany Harvey: Understood. I appreciate that context, Dr. Taplitz. So then, next, Dr. Law, I'd like to review the key recommendations of this guideline. The guideline addresses four overarching clinical questions. So starting with the first question, what are the recommended routine preventative vaccinations for adults with cancer? Dr. Lisa Law: Thank you, Brittany. Before I start, I just want to wholeheartedly thank the first author of this paper, Dr. Mini Kamboj, Dr. Elise Kohn from the NCI, as well as the ASCO staff in putting this publication and guideline together. It is a very, very important guideline, and I echo everything Dr. Taplitz just said. So going back to your question, what are the recommended routine preventative vaccines for adults with cancer? As per this guideline, there are about 7 to 8 based on patient age and risk. Namely, they are: seasonal flu, RSV for those aged 60 or above, COVID-19, Tdap, Hepatitis B, Shingrix, Pneumococcal vaccine, and the HPV vaccine. These vaccines should ideally be given two to four weeks before therapy. However, non-live vaccines can be given anytime during or after chemo, immunotherapy, hormonal treatment, radiation, or surgery. Brittany Harvey: Excellent. Thank you for reviewing those vaccinations and the timing of them as well. So then, following those recommendations, Dr. Taplitz, what additional vaccinations and revaccinations are recommended for adults undergoing hematopoietic stem cell transplantation, CD19 CAR-T treatment, or B-cell depleting therapy? Dr. Randy Taplitz: Many studies have shown that stem cell transplant recipients essentially lose immunity from childhood immunizations, and we know that these individuals are very vulnerable to infection, particularly in the first year after transplant. Revaccination is critical to help restore their immunity. The optimal timing of vaccination is based on our understanding of adequate immune reconstitution with B and T-cell recovery so that the individual can mount a response to the vaccine. We know that a lot of factors influence this immune reconstitution, including the age of the stem cell transplant recipient, the source of the donor, the time from transplant, graft-versus-host disease prophylaxis, the treatment and severity of graft-versus-host disease, and the vaccine type and antigens used. There are a number of bodies throughout the world, IDSA as I mentioned, CDC, American Society for Transplant and Cellular Therapy, European Society for Blood and Marrow Transplant, and European Conference for Infections and Leukemia. All of these bodies have guidelines that approach vaccination in stem cell transplants. However, variation does exist in the use of a variety of things including whether to use immune predictors to help guide vaccination, and there is really not consensus on whether this immune predictor guided vaccination is more likely to produce a protective immune response versus a standardized schedule. In addition, the duration of protection is incompletely understood. The bottom line in these guidelines is that they recommend complete revaccination starting for most vaccines at 6 to 12 months after stem cell transplant, in order to restore vaccine-induced immunity. And I just want to go through a few of the particulars. For COVID-19, which is a three-dose series in the primary series, influenza - generally high-dose influenza - and pneumococcal vaccine, PCV20 in general, ultimately four doses, can be administered, starting as early as three months after transplant. Although there is really not much data to guide the use of the recombinant zoster vaccine in allogeneic stem cell transplant, the vaccine can be administered after the end of antiviral prophylaxis, which in general is 12 to 18 months after allogeneic and 3 to 12 months after autologous stem cell transplant. Some of the other vaccines, such as hepatitis B, Tdap, meningococcal vaccines, and HPV revaccination in those less than 45 are also recommended. I want to also spend the moment talking about the two recently licensed RSV vaccines, which were essentially studied in less compromised hosts and really without any immunogenicity data in stem cell transplant, and thus, there is no recommendation in this guideline for the use of these vaccines after transplant. Live vaccines, such as MMR and varicella – varicella would be in varicella-seronegative patients without a prior history of varicella – should be delayed for at least two years and only given in the absence of active graft-versus-host disease or immunosuppression. Moving briefly to CAR T, which is an immunotherapy that involves adoptive cell therapy, given the available data and after a review by the group, it was recommended that adults with hematopoietic malignancies receiving CAR T therapy directed against B-cell antigens should receive influenza and COVID-19 vaccines either two weeks before lymphodepletion or no sooner than three months after the completion of therapy. Administration of non-live vaccines preferably should occur before CAR T treatment or at least 6 to 12 months after, following the same timing as what we recommend for stem cell transplant. There is really little data to guide the safety and timing of administration of live vaccines after CAR T therapy. In terms of adults receiving B-cell depleting therapy, they are generally unable for time to mount an effective humoral response but may have at least partially intact cellular immune responses. They are encouraged to be revaccinated for COVID-19 no sooner than six months after completion of B-cell depleting therapy, and they should receive influenza vaccine approximately four weeks from the most recent treatment dose for patients on chronic therapy. For other non-seasonal immunizations, vaccines ideally should be given two to four weeks before commencing anti-CD20 therapy or delayed until 6 to 12 months after completion, except for the recombinant zoster vaccine, which can be given one month after the most recent dose of B-cell depleting therapy. Brittany Harvey: I appreciate you reviewing each of those vaccinations and when they should be given, and reviewing the available data – albeit, limited data – in these situations. So beyond these routine preventative vaccinations and revaccinations that you've both just described, Dr. Law, what additional vaccinations does the expert panel recommend for adults with cancer traveling outside the United States? Dr. Lisa Law: Good question. As per these ASCO guidelines, adults with solid or blood cancer traveling outside of the United States should follow the CDC standard recommendations for their destination. For the 2024 CDC Yellow Book, travel vaccines, in general, should be delayed until three months from the last chemotherapy or, and for those with solid tumors, ideally when the disease is in remission. Of note, hepatitis A, typhoid, inactivated polio, Hep B, rabies, meningococcal vaccine, and Japanese encephalitis vaccines are considered to be safe. In all cases of travel, patients should be counseled by their healthcare provider about the travel timing, with the additional attention to the regional seasonality of infections, for instance, influenza is more common in late summer in Australia, and also with attention to any outbreaks that may be occurring globally at the time of travel. Brittany Harvey: Absolutely. Those are key points for clinicians to discuss with their patients as they consider upcoming travel. So then, the final clinical question that the panel addressed, Dr. Taplitz, what vaccinations does the panel recommend for household and close contacts of adults with cancer? Dr. Randy Taplitz: Thank you. Yes, it is recommended that all household members and close contacts, when possible, be up to date on their vaccinations. And the only further thing I would say is that there are some special considerations for the use of live vaccines in household contacts, particularly in stem cell transplant recipients. Contacts of people who receive stem cell transplants should preferably receive inactivated influenza vaccines. As was mentioned, MMR and varicella vaccines are both safe to administer to close contacts. Vaccine strain transmission to immunocompromised hosts has not been associated with MMR use in family members. Eleven cases of the varicella vaccine strain transmission are described in the published literature, but none occurred in compromised hosts. Because the vaccine strain can cause severe and fatal varicella in profoundly immunocompromised people, precautions are advised to avoid close contact with a person with a vaccine-induced rash. For household contact travelers, MMR and yellow fever vaccines are considered safe. Oral cholera should be avoided. For smallpox vaccines, the second-generation ACAM2000 has rarely been associated with vaccinia transmission and should be avoided because of this. But the live replication-deficient MVA-based JYNNEOS vaccine is felt to be safe for household contacts of immunocompromised individuals. Brittany Harvey: I appreciate you reviewing the importance of vaccination for household and close contacts, and some of those precautions that individuals should take. I appreciate you both for reviewing all of these recommendations. So then in your view, Dr. Law, what is the importance of this guideline, and how will it impact both clinicians and adults with cancer? Dr. Lisa Law: In my opinion, this is a very important guideline that is long overdue in the oncology community and will have a huge impact on both clinicians and adults with cancer. Over the years, I have often been asked by my colleagues and patients, “Can I have the flu vaccine, and if so, when?” So this guideline really is going to be helpful. More importantly, our cancer patients are living much longer. They may have years of quality of life even with third or fourth line of treatment, especially, for instance, like CAR T for myeloma and lymphoma. However, we know that with additional treatment, that carries a substantial risk of infection complication among these immunocompromised patients. So it is of paramount importance to inform our patients and colleagues to be proactive in advocating preventive therapy ahead of time, meaning trying to get the patients appropriately vaccinated as early as possible to generate immunity. Another case in point is the Shingrix vaccine. I used to see lots of shingles, but ever since we have the recombinant Shingrix, I have fewer encounters. And this is huge because post-herpetic neuralgia robs a patient's quality of life. So, again, it is very important to recommend appropriate vaccines for our cancer patients. Brittany Harvey: Absolutely. It is key to ensure patients receive these preventative vaccines, and we hope that this guideline puts an emphasis on that for clinicians and patients. So finally, to wrap us up, Dr. Taplitz, what are the current gaps in knowledge regarding the vaccination of people with cancer? Dr. Randy Taplitz: There are a number of really important gaps in knowledge and really critical unmet needs that require research and other dedicated efforts. Among these are, and I think paramount, are really the participation of people with cancer with varied types of immunocompromise in vaccine trials. Where vaccine trials are only for cancer patients, obviously is ideal, testing vaccines in the appropriate population. But when that's not feasible, pre-existing cancer should not preclude eligibility, and inclusion of cohorts of people receiving anticancer treatment should be incorporated prospectively. So that's really critical because the quality of our guidelines is based upon the data. We use the data for developing guidelines and gathering more data in the particular patient population is really, really critical. Secondly, work for creating more immunogenic vaccines and research to understand the immune response to vaccines after immuno-depleting therapies, particularly with newer therapies such as CAR T and newer B cell therapies, bispecific antibodies, etc. is really critical. We need to really understand the immune response and have the most potent vaccines available to these people who may have impaired immune responses. Switching gears a little bit, we really need mechanisms to promote institutional commitment to integrate and sustain immunization best practices for people with cancer. This will largely be through multidisciplinary, team-based approaches, protocol-based vaccination standing orders, and leveraging data sharing so that we can all be on the same page with giving vaccines to these individuals. We also need education and evidence-based decision-making tools, emphasizing preventive care through immunization, the availability of educational resources to clinicians and patients to address commonly asked questions and also misconceptions about vaccination, that's absolutely critical. And finally, I think we need to develop strategies for addressing unique challenges and factors contributing to vaccine hesitancy during cancer therapy. We need to focus on patient and clinician communication, and very importantly, we need to consider health equity considerations in the development and approach to vaccines in these compromised patients. Brittany Harvey: Definitely, we'll look forward to research and advances in these areas that you've just described to support these guidelines and increase vaccine uptake. So I want to thank you both so much for your work on this important guideline, and thank you for your time today, Dr. Law and Dr. Taplitz. Dr. Lisa Law: Thank you. Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/supportive-care-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast, and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
IDSA President Steven Schmitt, MD, FIDSA, Vera Luther, MD, FIDSA and Emily Blumberg, MD, FIDSA analyze the results of the recent ID Match and discuss IDSA's strategies for bolstering the ID workforce.
In this episode, Emily Heil, PharmD, MS, BCIDP, AAHIVP; Laila Woc-Colburn, MD; and Trevor Van Schooneveld, MD, FSHEA, FACP, discuss their approach to managing infections involving Pseudomonas aeruginosa with difficult-to-treat resistance, including: Mechanisms of β-lactam resistanceEffect of resistance mechanism on susceptibility to antipseudomonal agent2023 IDSA guidance recommendations Activity against newer antipseudomonal β-lactams in the United StatesThe latest clinical data by antimicrobial regimen: - Ceftolozane/tazobactam - Ceftazidime/avibactam - Imipenem/cilastatin/relebactam - CefiderocolApplying antimicrobial stewardship principlesProgram Director:Trevor Van Schooneveld, MD, FSHEA, FACP Professor, Division of Infectious DiseasesProgram Director, Infectious Diseases FellowshipMedical Director, Antimicrobial Stewardship ProgramUniversity of Nebraska Medical CenterOmaha, NebraskaFaculty:Emily Heil, PharmD, MS, BCIDP, AAHIVPAssociate ProfessorDepartment of PharmacyUniversity of Maryland School of PharmacyID Clinical Pharmacy SpecialistUniversity of Maryland Medical Center|Baltimore, MarylandLaila Woc-Colburn, MDAssociate ProfessorDivision of Infectious DiseasesEmory University School of Medicine Atlanta, GeorgiaContent based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://clinicaloptions.com/CE-CME/infectious-disease/cmv-prevention-in-sot-recipients/26139Link to full program: https://bit.ly/40HyvPy
In this episode,Emily Heil, PharmD, MS, BCIDP, AAHIVP; Laila Woc-Colburn, MD; and Trevor Van Schooneveld, MD, FSHEA, FACP, discuss their approach to managing infections caused by NDM-producing Enterobacterales, including: Ambler classification of β-lactamasesMechanisms of resistance2023 IDSA guidance recommendationsThe latest clinical data by antimicrobial regimen:Ceftazidime/avibactam and aztreonamCefiderocolInvestigational aztreonam/avibactamClinical case of NDM-producing E. coli with pan-β-lactam resistanceProgram Director:Trevor Van Schooneveld, MD, FSHEA, FACP Professor, Division of Infectious DiseasesProgram Director, Infectious Diseases FellowshipMedical Director, Antimicrobial Stewardship ProgramUniversity of Nebraska Medical CenterOmaha, NebraskaFaculty:Emily Heil, PharmD, MS, BCIDP, AAHIVPAssociate ProfessorDepartment of PharmacyUniversity of Maryland School of PharmacyID Clinical Pharmacy SpecialistUniversity of Maryland Medical CenterBaltimore, MarylandLaila Woc-Colburn, MDAssociate ProfessorDivision of Infectious DiseasesEmory University School of Medicine Atlanta, GeorgiaContent based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://bit.ly/476v2wILink to full program:https://bit.ly/40HyvPy
In this episode, Emily Heil, PharmD, MS, BCIDP, AAHIVP; Laila Woc-Colburn, MD; and Trevor Van Schooneveld, MD, FSHEA, FACP, discuss their approach to managing infections involving carbapenem-resistant Acinetobacter baumannii (CRAB), including: Mechanisms for β-lactam resistanceAdditional resistance mechanisms and virulence factors2023 IDSA guidance recommendations for moderate to severe CRAB infectionsThe latest clinical data by antimicrobial therapy/regimen:SulbactamMeropenem and colistinCarbapenem, sulbactam, and polymyxin BTetracyclinesCefiderocolSulbactam/durlobactam and carbapenems Program Director:Trevor Van Schooneveld, MD, FSHEA, FACP Professor, Division of Infectious DiseasesProgram Director, Infectious Diseases FellowshipMedical Director, Antimicrobial Stewardship ProgramUniversity of Nebraska Medical CenterOmaha, NebraskaFaculty:Emily Heil, PharmD, MS, BCIDP, AAHIVPAssociate ProfessorDepartment of PharmacyUniversity of Maryland School of PharmacyID Clinical Pharmacy SpecialistUniversity of Maryland Medical CenterBaltimore, MarylandLaila Woc-Colburn, MDAssociate ProfessorDivision of Infectious DiseasesEmory University School of Medicine Atlanta, GeorgiaContent based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://bit.ly/476v2wILink to full program: https://bit.ly/40Mmicz
Guest: Jeff Reich, Executive Director of Identity Defined Security Alliance [@idsalliance]On Linkedin | https://www.linkedin.com/in/jreich/On Twitter | https://twitter.com/JeffReichCSOOn YouTube | https://www.youtube.com/channel/UC8yfa2vRYDjS7TUWKAHIrwg____________________________Host: Sean Martin, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining CyberSecurity Podcast [@RedefiningCyber]On ITSPmagazine | https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/sean-martin____________________________This Episode's SponsorsImperva | https://itspm.ag/imperva277117988Pentera | https://itspm.ag/penteri67a___________________________Episode NotesIn this episode of Redefining CybersSecurity, host Sean Martin connects with Jeff Rich to dive deep into the world of digital identities and identity management. Through their lively and thought-provoking conversation, they explore various aspects of identities, from multiple personas in apps to the challenges and risks associated with identity sharing.They discuss the impact of cloud adoption and remote work on identity security, emphasizing the need for organizations to prioritize securing digital identities. They also touch on the role of artificial identities in smart devices and cars, and how AI and machine learning can be utilized in identity use cases.Throughout the episode, Sean and Jeff bring a philosophical and science fiction perspective to the topic, using metaphors and engaging storytelling techniques to captivate listeners. They highlight the importance of policy and control in identity management, and the need for organizations to take proactive measures in securing digital identities. They also provide valuable insights from a research survey, revealing that identity security is a top priority for a significant percentage of organizations.They emphasize the complexities of identity management and the evolving nature of identities in today's digital landscape. Overall, this episode offers a captivating and informative discussion on digital identities, leaving listeners with valuable takeaways and a deeper understanding of the importance of identity security in the modern world.____________________________Watch this and other videos on ITSPmagazine's YouTube ChannelRedefining CyberSecurity Podcast with Sean Martin, CISSP playlist:
IDSA President Steven Schmitt, MD, FIDSA, Wendy Armstrong, MD, FIDSA, Erin Bonura, MD, FIDSA, discuss the upcoming ID Match, their projections, what it means for the field and how IDSA is addressing ID workforce needs.
Neste episódio, você ficará por dentro do que foi abordado no IDWeek, fórum anual promovido pela Infectious Diseases Society of America (IDSA). Realizado em Boston, nos Estados Unidos, entre os dias 11 e 15 de outubro de 2023, o congresso teve como temas centrais o PEPFAR (Plano de Emergência do Presidente dos EUA para combater à AIDS), muita discussão sobre o HIV e outras infecções sexualmente transmissíveis, além do que podemos esperar para os novos guidelines da IDSA. Escute agora! Confira esse e outros posts no Portal PEBMED e siga nossas redes sociais! Facebook Instagram Linkedin Twitter
In this episode of the Identity at the Center Podcast, Jeff interviews Jeff Reich, the Executive Director of the Identity Defined Security Alliance (IDSA), at the 2023 Identity Week America conference. They discuss the latest updates from the IDSA, including Cybersecurity Awareness Month in October, collaboration with the Secure Identity Alliance, and the upcoming Identity Management Day on April 9th, 2024. The conversation also explores the value of attending conferences like Identity Week America, particularly in terms of gaining insights from industry experts and networking opportunities. Jeff Reich shares his experience with government involvement in identity security, considering the significant government attendance at the conference. The episode wraps up with a lighthearted question about the "best worst thing" happening in identity. Connect with Jeff Reich: https://www.linkedin.com/in/jreich/ Learn more about the IDSA: https://www.idsalliance.org/ Learn more about the SIA: https://secureidentityalliance.org/ Connect with us on LinkedIn: Jim McDonald: https://www.linkedin.com/in/jimmcdonaldpmp/ Jeff Steadman: https://www.linkedin.com/in/jeffsteadman/ Visit the show on the web at idacpodcast.com and follow @IDACPodcast on Twitter.
In which we talk about management of intermediate chest pain (including Cardiac CT Angiography vs Invasive Coronary Angiography, as well as Functional Stress testing), and review CKC pulmonary topics involving IDSA guidelines for Community Aquired Pneumonia treatment and Antithrombotics in VTE. | 00:00 Intro | | 00:38 TOC | | 01:18 CT vs ICA in intermediate chest pain (NEJM 2021) | | 02:59 TWDFNR - functional testing vs CCTA (JHM 2023, ACC 2022) | | 04:50 CAP review (IDSA 2019) | | 07:42 Antithrombotic therapy in VTE (Chest 2021) | | 11:22 Closing | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.] Review content summarized by UCSF DHM CKC. Music by Amit Apte. Icon Vectors by Vecteezy.
“We want individuals that are practicing in the ID field to feel that IDSA is their home, that they have the support of IDSA in their endeavors.” In September 2023, IDSA introduced a new volunteer structure to better engage members and support its strategic initiatives. In this episode, IDSA President Carlos del Rio, MD, FIDSA and Vice President Tina Tan, MD, FIDSA discuss the decision behind the restructure and explain the differences moving forward.
Only 50% of infectious diseases fellowship positions are filled each year, a growing issue that can be attributed to the financial impact of working in a non-procedural specialty. In episode two of a two-part series on addressing ID compensation, host Buddy Creech, MD, MPH, FPIDS speaks with IDSA Immediate Past President Daniel McQuillen, MD, FIDSA to discuss what IDSA has been doing over the last three decades to address these fundamental issues.
Subscribe to the Design Better Podcast on Substack to get episodes a week early and other bonus content: https://designbetterpodcast.com/ Show notes: https://designbetterpodcast.com/p/georg-petschnigg-product-design-and#details *** The New York Times has gone through many challenges and evolutions during its storied history. Founded in 1851—when it was called the New-York Daily Times—it faced draft riots during the Civil War, received the first telegraph transmission from a naval battle in 1904, and was involved in libel suits in the 1960's that helped establish freedom of the press through the US Supreme Court But it's within the past 25 years or so that the “Newspaper of Record” has undergone some of its most radical transformations: shifting much of its focus away from the printed page to the web and app ecosystem, and expanding into food with NYT Cooking, consumer product reviews with The Wirecutter, and podcasts with The Daily. Today we chat with Georg Petschnigg, SVP of Product Design at the New York Times, about what it takes to balance the tension between the rich legacy of the Times with the rapidly evolving digital landscape. We also talk about designing across products and platforms for a more unified experience, creating a tight coupling between design and engineering, and what the future holds for news products in a world where AI and ML can facilitate content creation but also manufacture deception. Before we get to the show, we wanted to let you know about a cool project that our friend Felix Lee started called ADPList. If you're early in your career, or if you're in the midst of a transition, you might want to connect with top-notch professionals in design. Well, now you can now tap into the knowledge and wisdom of some of the most prominent figures in the design industry. And best of all, it's completely free! ADPList is a community platform on a mission to democratize mentorship for all, with over 16,000 verified mentors contributing worldwide; opening up an entire world of possibilities for mentorship and networking. Join ADPList today—for free—and accelerate your career growth. Visit https://dbtr.co/adplist Bio Georg Petschnigg is an executive, entrepreneur, and product leader. He feels most comfortable at the intersection of design, technology, and business. He currently serves as Head of Product Design at The New York Times. Throughout his career, he's created products that changed how people work, create, and see the world. He believes technology needs to serve the human need to create. Georg co-founded FiftyThree in 2011 and served as CEO until WeTransfer's acquisition in 2018. FiftyThree are the makers of Paper®, the fast and beautiful productivity app for getting ideas down, Paste® the fastest way for teams to share and gather around their ideas, and Pencil, the award-winning stylus. Internationally recognized for design excellence and innovation, they've received awards from Apple, IDSA, Communication Arts, and IxDA. FiftyThree's products reach more than 30 Million creative thinkers worldwide and defined mobile creativity. This episode is brought to you by: Methodical Coffee: Roasted, blended, brewed, served and perfected by verified coffee nerds
Deepak Menon is Vice President at Microsoft India, leading the Product Experience, Design and Research teams across products in the Experience & Devices (E+D) and Security, Compliance, Identity and Compliance (SCIM) divisions at Microsoft India. They include products like Windows, Teams, Office, Edge, Search, Bing, OneDrive, SharePoint, Outlook, and Loop. Deepak's team helped define the enquiry around ‘What is productivity for billions of mobile-only users', which has led to product innovations like Kaizala and Microsoft Office – mobile products that help businesses connect with their value chain to collaborate and complete consumer and business workflows. Deepak was also responsible for designing and defining the Ribbon interface for Microsoft Office. He was also the driver for the Microsoft Centre for Information work, which reimagined the future of productivity and won the IDSA gold reward in 2003. Deepak has worked at Google leading User Experience teams in India and Seattle. He was also the Chief Product and Customer officer at Myntra, leading teams across multiple functions. Deepak completed his B.Arch. from REC. Trichy, his M.Arch. on a fellowship and M.F.A. from The Ohio State University. He loves sports and lives in Hyderabad with his wife, Ashwini, two sons, Adhvai & Prathyai and his dog Dash. Join us as we delve into the pivotal role of design in driving innovation within organizations. Deepak shares a compelling project Kaizala, where design proved crucial in fostering innovation and illuminated the powerful impact of design thinking on transformative outcomes. In this episode, we explore the indispensable roles of diversity and empathy in the design process when aiming for innovation. Deepak unravels how embracing diverse perspectives and empathetic approaches unlocks the potential for groundbreaking solutions and user-centric experiences. Discover the art of balancing practicality and creativity in the quest for innovative design. Learn how to cultivate a collaborative, interdisciplinary environment where design seamlessly integrates with engineering, marketing, and product management functions. We unveiled effective strategies for nurturing innovation through harmonious cross-functional collaboration. Get insights on approaching emerging technologies and trends in design innovation. Deepak gives invaluable tips on staying ahead of the curve, leveraging cutting-edge advancements, and navigating the ever-evolving landscape of emerging technologies to drive innovative design solutions. Embark on a journey of technological promise as our guest unveils their excitement for emerging technologies and trends driving innovation in design. Discover the transformative potential of groundbreaking advancements and explore the untapped possibilities that lie ahead. Please tune in to our podcast, Designing for Innovation: Unleashing Creative Brilliance, as we engage in thought-provoking conversations with Deepak Menon, uncovering the transformative power of design in driving innovation. Book Recommendation by Deepak Menon Made to Stick: Why Some Ideas Survive, and Others Die - Chip Heath Guns, Germs And Steel - Jared Diamond Seeking Wisdom: From Darwin to Munger - Peter Bevelin Thank you for listening to this episode of Nodes of Design. We hope you enjoy the Nodes of Design Podcast on your favourite podcast platforms- Apple Podcast, Spotify, Google Podcasts, Amazon Music, and many more. If this episode helped you understand and learn something new, please share and join the knowledge-sharing community #Spreadknowledge. This podcast aims to make design education accessible to all. Nodes of Design is a non-profit and self-sponsored initiative by Tejj.
Youtube flagged my content for PII violations, but what did I do to get put in the penalty box? CISO's plan on investing more for cybersecurity over the next few years, new research from Nuspire indicates the growing spending trend. Mitiga has found some configuration issues with Gdrive and Gsuite, what should businesses know to defend themselves? Armorblox says brand impersonation is increasing, how much of a threat is this type of attack? Gigabyte hardware and firmware has been found to be shipped with embedded back doors, uh oh. The IDSA has produced some new research on the status of iam and strategy, what can we learn from that? And G2 has unbiased reviews on security tooling and solutions, what can you learn from visiting that site. Those points and more on this episode!
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:Current COVID-19 landscapeRapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Long COVIDPresenters:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of MedicineUniversity of ChicagoChicago, IllinoisTrinh P. Vu, PharmD, BCIDPClinical Pharmacy Specialist in Infectious DiseasesDepartment of Pharmaceutical ServicesEmory University Hospital MidtownAtlanta, GeorgiaTo download the slides: bit.ly/3oHKC09To view the full online program: bit.ly/4201xcO
Guest: Jeff Reich, Executive Director of Identity Defined Security Alliance [@idsalliance]On Twitter | https://twitter.com/JeffReichCSOOn LinkedIn | https://www.linkedin.com/in/jreich/On YouTube | https://www.youtube.com/channel/UC8yfa2vRYDjS7TUWKAHIrwg____________________________Host: Deb RadcliffOn ITSPmagazine
Show notes: https://designbetterpodcast.com/p/kevin-bethune-reimagining-design Not many people can say they've gone from being a nuclear engineer to helping design Air Jordans at Nike. But that's part of Kevin Bethune's story, and today we chat with him about his journey from engineering to design. Kevin also published a best-selling book last year called Reimagining Design: Unlocking Strategic Innovation. We talk about what he hoped to learn from writing the book, and discuss a critique of design thinking, the role of rigor in creativity, and the rewards and challenges of working with multidisciplinary teams. Bio Kevin Bethune is a Design and innovation executive leader serving, scaling and leading creative teams as large as 30+ nationwide, and influencing global teams as large as 70+ in the definition of design functional excellence and innovation best practices while respecting local differences. He's also an entrepreneur and founder of dreams • design + life, a “think tank” combining strategic design and industrial design to address human-centric and holistic opportunities to solve latent needs across industries that benefit from integrated physical, digital and service-oriented experiences. Kevin is a globally recognized speaker who's given talks at TED, DMI, IDSA, AIGA, MIT, Northwestern, Carnegie Mellon, Notre Dame, ArtCenter, Lucerne, Nike, BCG and Google Design. * Help us make the show even better by taking a short survey: www.dbtr.co/survey If you're interested in sponsoring the show, please contact us at: sponsors@thecuriositydepartment.com If you'd like to submit a guest idea, please contact us at: contact@thecuriositydepartment.com * This episode is brought to you by: Fable: Build inclusive products: https://makeitfable.com/designbetter/ Freehand by InVision: The intelligent whiteboard that's half the price of Miro and Mural: https://freehandapp.com/ Methodical Coffee: Roasted, blended, brewed, served and perfected by verified coffee nerds: https://methodicalcoffee.com/ (use code "designbetter" for 10% off of your order). Athletic Greens: Build a foundation for better health: http://athleticgreens.com/designbetter
Telegram impersonation affects a cryptocurrency firm. Phishing with Facebook termination notices. Russian phishing continues to target Moldova. The IEEE on the impact of technology in 2023. Glass ceilings in tech leadership. Seattle Schools sue social media platforms. Malek Ben Salem from Accenture explains coding models. Our guest is Julie Smith, identity security leader and executive director at IDSA, with insights on identity and security strategies. And dealing with the implications of ChatGPT. For links to all of today's stories check out our CyberWire daily news briefing: https://thecyberwire.com/newsletters/daily-briefing/12/5 Selected reading. Breaking the glass ceiling: My journey to close the leadership gap (CyberWire's Creating Connections: Wrapping up the Year) Impact of Technology in 2023 and Beyond (IEEE) Telegram insider server access offered to Dark Web customers (SafetyDetectives) Moldovaʼs government hit by flood of phishing attacks (The Record from Recorded Future News) OPWNAI : Cybercriminals Starting to Use ChatGPT (Check Point Research) Hackers exploiting ChatGPT to write malicious codes to steal your data (Business Standard) Armed With ChatGPT, Cybercriminals Build Malware And Plot Fake Girl Bots (Forbes) Hackers Exploiting OpenAI's ChatGPT to Deploy Malware (HackRead) Cybercriminals are already using ChatGPT to own you (SC Media) Threat Report: Impersonation Detected in Telegram Chats to Deliver Malware (Safeguard Cyber) Seattle schools sue tech giants over social media harm (ABC News) Seattle Public Schools sues TikTok, YouTube, Instagram and others, seeking compensation for youth mental health crisis (GeekWire) Ghost Writer: Microsoft Looks to Add OpenAI's Chatbot Technology to Word, Email (The Information) Microsoft plans to use ChatGPT in Bing. Here's why it could be a threat to Google. (Freethink) ChatGPT Hits Ethical Roadblock; Blocked (Analytics India Magazine) A College Kid Built an App That Sniffs Out Text Penned by AI (The Daily Beast) A Princeton student built an app which can detect if ChatGPT wrote an essay to combat AI-based plagiarism (Business Insider)
We are back for another great interview on our podcast on how to unlock your world of creativity. Our guest today is Dan Klitsner. He joins us on our around the world journey where we talk to creative practitioners about how they get inspired and how they organize and pitch those ideas, and also how they gain the confidence and the connections to launch their work out into the world. Dan is the founder and creative director of toy inventing and licensing firm KID Group LLC. He is also the inventor of the iconic Bop It, a wildly successful children's toy that has sold over 30+ million units since 1996. He is also a recipient of 2 gold IDEA awards and 4 Toy of the Year Awards. He also co-founded QiGo Inc., which utilizes USB Key technology to support child-safe internet connections for toys. We talk about the Art of the pitch seeing as Dan has been on both sides of the table. He has done several pitches for several toys and has served as a judge in many design and innovation competitions as well, including the IDSA international design competition, the Consumer Electronics Show, and the Toy of the Year Awards. He also teaches classes in design and invention at the California College of Arts, San Francisco State, and the San Francisco Academy of Art. We also hear about “Bop it for Good” which is Dan's latest project, taking the success of the Bop It and turning it into a force for change for the underserved communities and especially children. Through the Bop It for Good program, 100% of his profits through the website will go to Boys and Girls Clubs in underserved areas to provide assistance and programs to children. This is in recognition of the 25th anniversary of the Bop It. His top tips on the art of pitching are: Remember that Pitching, in general, is so fun especially If you are an idea person. It is very important how you choose to pitch, depending on the idea. Because there isn't just one way to pitch ideas. There are many ideas and you have to figure out what is a compelling way to get people, to love your idea. Knowing your audience is the most important thing before you pitch. The secret to a great pitch is to make sure to keep it loose. In conclusion, Dan walks us through the creative process that goes into making and designing the products that are around for generations. And also he explains the exact process of going from an idea to licensing it, patenting it and bringing it to market, and selling millions of units. You can find more information about Dan's work and interact with him on social media The Bop It for Good Kickstarter program: https://bopitforgood.com (https://bopitforgood.com) Instagram: https://www.instagram.com/bopitinventor/ (bopitinventor) TikTok https://www.tiktok.com/search?q=bopitinventor&t=1651993606371 (bopitinventor)
© 2020-2025 Ivy Podcast Discovery LLC
